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ABSTRACT 
Purpose: The purpose of this project was to examine the effects of acute garlic supplementation 
on fibrinolytic potential and the fibrinolytic response to exercise in young healthy trained males. 
Methods: 18 healthy trained males (Age = 20.9 ± 2.2 years, Height = 178 ± 7.7 cm, Weight = 
75.5 ± 9.6 kg, VO2max =  59.8 ± 6.7 ml kg
-1 min-1) performed a graded treadmill test to volitional 
exhaustion. Blood samples were taken at rest, within two minutes post-exercise, and one hour 
post-exercise. Participants were randomly assigned to ingest either 900 mg of powdered garlic or 
a placebo three hours before the exercise session. The supplement was distributed in a double-
blind, crossover fashion.  Participants repeated the protocol with the other treatment after a 14-
day washout period. Paired t-tests were used to compare height, weight, resting hematocrit, 
VO2max, respiratory exchange ratio, and treadmill time between the two trials. A two-factor 
(treatment and time) repeated measures analysis of variance (ANOVA) was used to assess 
changes in tPA activity, tPA antigen, and PAI-1 activity. A priori statistical significance was set 
at P <0.05. Results: A significant difference was found between the two treatment conditions for 
absolute and relative VO2max. No significant differences were observed between the two 
treatment conditions for treadmill time or respiratory exchange ratio at VO2max. There was no 
main effect for treatment and no treatment x time interaction for any of the fibrinolytic variables 
examined. Conclusion: Acute garlic supplementation does not alter fibrinolytic potential or the 
fibrinolytic response to exercise in young healthy trained males. Acute garlic supplementation 
does, however, cause a small but statistically significant increase in VO2max. It remains unclear 
if this increase in VO2max is of functional importance. 
 
  
Chapter One 
Introduction 
The relative risk of myocardial infarction is 5.9 fold greater in the hour after vigorous 
exercise (Mittleman, et al. 1993). In the general population, the mechanism triggering the 
majority of cardiovascular events is the disruption of a vulnerable atherosclerotic plaque resulting 
in an occlusive thrombus (Giri et al., 1999) and studies examining individuals with exertion-
related myocardial infarctions suggest a similar pathological process (Ciampricotti et al., 1990). 
Consequently, the post-exercise period may be a hazardous time for those at risk of coronary 
events. One of the major factors which determines if an atheroscleoritc plaque will become 
occlusive is the hemostatic balance in the blood (Nagelkirk, 2010). Since 4% to 15% of 
myocardial infarctions are exertion-related (Tofler, 1990), methods which reduce prothrombotic 
or increase antithrombotic hemostatic forces during exercise may be clinically significant. 
Fibrinolysis, defined as the capacity to lyse insoluble fibrin clots, is primarily regulated 
by tissue plasminogen activator (tPA) (Collen & Lijnen, 1986) and the main circulating inhibitor 
of tPA; plasminogen activator inhibitor-1 (PAI-1) (Schleef & Loskutoff, 1988). tPA is a serine 
protease that activates the fibrinolytic system by converting the pro-enzyme plasminogen to the 
active enzyme plasmin, which then subsequently dissolves fibrin into fibrin degradation products  
(Gebbink, 2011). tPA is stored in small vesicles within vascular endothelial cells (Emeis et al., 
1997) and is released in the presence of a variety of stimuli, especially increased levels of 
epinephrine (Chandler et al., 1992). PAI-1 is a serine protease inhibitor that inhibits the 
fibrinolytic system by acting as a substrate to tPA. The resulting cleavage of PAI-1 by tPA results 
in covalent binding of PAI-1 to tPA in a stable inactive 1:1: stochiometric complex (Gebbink, 
2011).  
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PAI-1 is produced by endothelial cells in an active form and is then secreted into the 
blood where it rapidly forms an inactive complex with tPA or it is released into the 
subendothelium where it binds to the extracellular matrix (Schleef & Loskutoff, 1988). PAI-1 is 
also produced by adipocytes in response to habitual elevations in tumor necrosis factor, insulin, 
and transforming growth factor beta (Alessi & Juhan-Vague, 2006). Regulation of PAI-1 occurs 
through a variety of mechanisms including endotoxin, thrombin, transforming growth factor β, 
and inflammatory cytokines (Schleef & Loskutoff, 1988). Coagulation, defined as the capacity to 
form insoluble fibrin clots, is achieved through a sequential process by which multiple inactive 
coagulation factors are converted to their active enzymatic form (Smith, 2003), ultimately 
resulting in conversion of prothrombin to thrombin. During exercise, markers of coagulation rise 
and remain elevated for hours into the post-exercise period (Hansen et al, 1990; Van Den Burg et 
al., 1995; Vanden Burg et al. 1997; Weiss et al. 1998; Hedge et al. 2000; Hillberg et al, 2003; 
Hillberg et al., 2003; Paton et al. 2004; Acil et al., 2007). Fibrinolysis also increases during 
exercise and thus maintains a balanced hemostatic environment (Chandler et al., 1992; Van Den 
Burg et al., 1995; Symanski et al., 1996; Van Den Burg et al., 1997; Fernhall et al. 1998; Hedge 
et al., 2000, Womack et al., 2001, Womack et al, 2003). However, at the cessation of exercise, 
fibrinolysis decreases rapidly (Hansen et al. 1990; Van Den Burg et al. 1995; Van Den Burg et 
al., 1997; Weiss et al. 1998; Cooper et al., 2004) and one hour post-exercise there is no longer 
any enhancement of the fibrinolytic system (Hilberg et al. 2003; Paton et al., 2004; Womack et 
al., 2006). This subsequently results in a hemostatic imbalance during the post-exercise period 
that favors clot formation.  
For thousands of years the benefits of Garlic, Allium sativum, have been recognized and 
included in clinical treatment. In the codex of Ebers, an ancient Egyptian medical writing, garlic 
is written as an essential ingredient in 22 therapeutic formulas (Block, 1985). Hippocrates 
observed garlic to be an effective treatment for neoplasms as well as an effective diuretic (Singh 
& Singh, 2008).  The Roman physician Dios-corides prescribed garlic as vermifuge to the Roman 
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army (Block, 1985). The prophet Mohammad recommended garlic as a treatment for scorpion 
stings (Singh & Singh, 2008). In modern times, Garlic still has the reputation of a highly 
recognized medicinal plant. In the two world wars, garlic was used as an antiseptic agent to treat 
wounds and prevent gangrene (Essman, 1984; Block, 1985). In 1944 Cavallito & colleagues 
identified this antiseptic component of garlic and it subsequently became the subject of two US 
patents (Block, 1985; Amagase et al., 2001). Albert Schweitzer reported to have used garlic as a 
medical treatment for amoebic dysentery (Block, 1985).  
There are >3,000 scholarly publications which have examined and confirmed numerous 
therapeutic properties garlic (Amagase et al., 2001). One benefit is garlic’s ability to improve 
fibrinolysis. Studies from the late 1970s to early 1990s reported substantial increases in 
fibrinolytic activity after acute and chronic supplementation (Bordia et al., 1975; Bordia et al., 
1977, Bordia et al., 1978, Arora et al., 1981, Chutani & Bordia, 1981; Bordia et al., 1982; 
Gadkari et al. 1991). These studies also found garlic to be effective at enhancing fibrinolytic 
activity across a variety of forms including: raw garlic (Chutani & Bordia, 1981; Gadkari et al., 
1991), fried garlic (Chutani & Bordia, 1981), and the essential oil of garlic (Bordia et al., 1975; 
Bordia et al., 1978; Arora et al., 1981; Bordia et al., 1982). Although the results of these studies 
are encouraging, they are limited because they fail to identify the specific parts of the fibrinolytic 
system that are affected by garlic. This limitation is inherently derived from the use of the 
euglobulin clot lysis method of measuring fibrinolytic activity (Kowalski et al., 1959) instead of 
directly measuring changes in tPA and PAI-I levels. There are also no prior studies which have 
combined exercise with garlic supplementation to evaluate the fibrinolytic effects of garlic during 
the post-exercise period.  
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Aims and Hypothesis 
Aim 1- To determine if acute supplementation with garlic influences plasma tPA levels at rest, 
within 2-minutes following a cardiorespiratory fitness test, and 1-hour after completion of a 
cardiorespiratory fitness test as compared to a placebo. 
Hypothesis 1- Acute supplementation with garlic will increase plasma tPA activity and decrease 
plasma tPA antigen at rest and will elevate tPA activity and tPA antigen levels within 2-minutes 
following a cardiorespiratory fitness test and 1-hour after completion of a cardiorespiratory 
fitness test as compared to a placebo. 
Aim 2- To determine if acute supplementation with garlic influences plasma PAI-1 levels at rest, 
within 2-minutes following a cardiorespiratory fitness test, and 1-hour after completion of a 
cardiorespiratory fitness test as compared to a placebo. 
Hypothesis 2- Acute supplementation with garlic will decrease plasma PAI-1 levels at rest, within 
2-minutes following a cardiorespiratory fitness test, and 1-hour after completion of a 
cardiorespiratory fitness test as compared to a placebo. 
Significance of this Study 
To date only three studies have examined the effect of acute garlic supplementation on 
tPA levels in humans (Kiesewettier et al., 1990; Jung et al., 1991; Legnani et al., 1993). Only two 
studies have evaluated the effect of acute garlic supplementation on PAI-1 activity (Jung et al., 
1991; Legnani et al., 1993). Yet, there is no overall consensus between them regarding the ability 
of acute supplementation to enhance fibrinolytic potential. Kiesewettier & colleagues observed 
300 mg and 600 mg of powdered garlic to increase tPA activity 56% and 51%, respectively, after 
5 hours. Moreover, the 600 mg of powdered garlic was shown to improve tPA activity in all 
participants. Jung & colleagues in a similar study observed 900 mg of dried garlic to enhance tPA 
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activity by 86% after 5 hours. In contrast to these two studies, Legnani & colleagues administered 
900 mg of dried garlic powder and observed no significant change in tPA activity or antigen after 
2, 4, and 6 hours.  
It should also be realized that all of these studies had female participants (Kiesewettier et 
al., 1990; Jung et al., 1991; Legnani et al., 1993) and two of the studies had participants who were 
active tobacco smokers (Jung et al., 1991; Legnani et al., 1993). Cederblad et al. (1977) and 
Giardina et al., (2004) have observed fibrinolytic activity to be variable across the menstrual 
cycle. None of the three studies indicated if they standardized their female participants’ treatment 
trials to menstrual cycle status. Research has also shown smoking tobacco alters fibrinolysis by 
decreasing tPA activity and antigen levels (Newby et al., 1999; Pretorius et al., 2002) and also by 
decreasing the tPA/PAI-1 molar ratio (Barua et al., 2002). These two factors were controlled for 
in the present study. 
An additional strength of the current study is that it uniquely maximizes the potential to 
detect a difference between trials. Basal tPA and PAI-1 activity levels are low (Rijken et al., 
1983; Declerck et al., 1988). This necessitates either a large effect size or a large number of 
participants to detect differences in these variables at rest. Large changes in fibrinolysis occur 
when stress is applied to the cardiovascular system. Research has shown exercise to be a 
sufficient stress to observe differences in fibrinolytic potential between groups that are not readily 
available at rest (Hamouradtidis et al., 1988). Thus, exercise may increase the potential to observe 
differences in the fibrinolytic profile between the garlic and placebo trials. Lastly, the effects of 
garlic on the exercise induced alterations in fibrinolysis are not known. 
  
Chapter Two 
Review of the Literature 
Objective 
The objective of this chapter is to provide an overview of: 1) the effects of garlic 
supplementation on fibrinolytic potential, 2) the effects of acute exercise on fibrinolytic potential, 
3) the effects of acute exercise on coagulation potential, and 4) the methodological considerations 
for research involving hemostasis. 
Regulation of Fibrinolysis 
Fibrinolysis, defined as the capacity to lyse insoluble fibrin clots, is primarily regulated 
by tissue plasminogen activator (tPA) (Collen & Lijnen, 1986) and the main circulating inhibitor 
of tPA; plasminogen activator inhibitor-1 (PAI-1) (Schleef & Loskutoff, 1988). tPA is a protease 
which activates the fibrinolytic system through the conversion of the pro-enzyme plasminogen to 
the active enzyme plasmin (Gebbink, 2011). This subsequently results in the dissolution of fibrin 
into fibrin degradation products (Gebbink, 2011). tPA is stored within vascular endothelial cells 
(Emeis et al., 1997) and is released from the endothelium in response to a variety of stimuli. 
However, in regards to exercise, approximately half of the tPA release is due to increased 
circulation of epinephrine (Chandler et al., 1992).  
PAI-1 is a protease inhibitor, which inhibits the fibrinolytic system by acting as a 
substrate to tPA. Upon cleavage of PAI-1 by tPA, a covalent bond forms between the two 
producing an inactive complex (Gebbink, 2011). PAI-1 is also produced by endothelial cells in an 
active form and is then secreted into the blood where it rapidly forms an inactive complex with 
tPA (Schleef & Loskutoff, 1988). PAI-1 is also produced by adipocytes in response to habitual 
elevations in tumor necrosis factor, insulin, and transforming growth factor beta (Alessi & Juhan-
Vague 2006). Like tPA, the regulation of PAI-1 occurs through a variety of mechanisms 
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including endotoxin, thrombin, transforming growth factor β, and inflammatory cytokines 
(Schleef & Loskutoff, 1988).  
Effects of Garlic on Fibrinolysis 
Studies dating back to the late 1970s have demonstrated that garlic has the ability to 
positively affect fibrinolytic potential (Bordia et al., 1975; Bordia et al., 1977, Bordia et al., 1978, 
Arora et al., 1981, Chutani & Bordia, 1981; Bordia et al., 1982; Gadkari et al. 1991; Bordia et al., 
1998). These studies observed a wide range (15-130%) of fibrinolytic enhancement (Bordia et al., 
1975; Bordia et al., 1977; Bordia et al., 1978). This large range of observed values may be due to 
differences in dosage form. The essential oil of garlic (Bordia et al., 1975; Bordia et al, 1978; 
Arora et al., 1981) produced larger increases in fibrinolytic activity as compared to fried garlic 
(Chutani & Bordia, 1981;) and garlic with butter (Bordia et al., 1975; Bordia et al. 1982). This 
may be due to the fact that consuming a fatty diet produces hyperlipemia, which has been 
postulated to impair fibrinolytic potential (Bordia et al., 1975; Bordia et al., 1982). Luley & 
colleagues (1986) used dried garlic; however, no improvements in fibrinolytic potential were 
observed with its administration. The large range of observed values may also be due to 
differences in dosage amount. Bordia and colleagues (1977, 1978) observed a 130% in 
fibrinolytic activity, after three months of supplementing 1 gram of garlic oil per kilogram of 
bodyweight daily. Conversely, Gadkari and colleagues (1991) observed a smaller increase in 
fibrinolytic activity (21.8%) after 2 months of dosing with 10 grams of raw garlic daily. 
Similarly, Arora and colleagues (1981) used a smaller dose, 3.75 milligrams of garlic oil daily, 
which results in an observed 32.5% increase in fibrinolytic activity by 8 weeks.  
Interestingly, the literature also shows that garlic can enhance fibrinolytic activity after 
acute doses. Bordia and colleagues (1975) administered 50 grams of garlic along with 100 grams 
of butter to 10 healthy subjects. After 3 hours there was a 15% increase in fibrinolytic activity. 
Within the same study on a separate trial, men were fed 100g of butter and over the same time 
course saw a 49% decline in fibrinolytic activity. This strongly suggests an acute ability of garlic 
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to enhance the fibrinolytic system. Similarly, Chutani & Bordia (1981) compared the effect of 
fried and raw garlic on fibrinolytic activity in 20 patients with ischemic heart disease.  Garlic was 
administered in the morning in fried or raw doses amounting to 0.5 grams per kilogram of body 
weight. Fibrinolytic activity increased in the control group by 5% after 6 hours; however, this 
difference was not significant. In the experimental trials, fibrinolytic activity significantly 
increased by 72% and 63% six hours following the administration of raw and fried garlic, 
respectively. Moreover, these elevated levels of fibrinolytic activity were maintained up to 12 
hours after administration.  
The aforementioned studies strongly support the hypothesis that garlic supplementation 
can enhance the fibrinolytic system. However, the specific targets of improvement in the 
fibrinolytic system are unknown due to the use of euglobulin clot lysis time in these studies. The 
euglobulin clot lysis method is a technique that calls for the generation of a standard clot followed 
by recording the lysis time of said clot (Kowalski et al., 1958). This provides an adequate 
assessment of overall fibrinolytic activity; however, it does not allow researchers to specifically 
identify the aspects of the fibrinolytic system that are being altered by garlic supplementation. 
More recent studies have attempted to bypass this limitation by directly measuring tPA and PAI-1 
levels before and after garlic administration. Kiesewttier & colleagues (1990) administered single 
doses of 100 mg, 300 mg, and 600 mg of powdered garlic or placebo orally. Five hours following 
administration they observed a 56.3% and 51% increase in tPA activity in the 300 mg and 600 mg 
trials, respectively. Despite the similarities in overall percent increase, the 600 mg trial was the 
only dose that led to increased activity in all participants. Jung & colleagues (1991) similarly 
administered single doses of 900 mg of powdered garlic or placebo. Five hours after 
administration, tPA activity rose 86.1%. Legnani & colleagues (1993) administered a single dose 
of 900 mg of powdered garlic as well. tPA activity levels increased 300% after 4 hours and 406% 
after 6 hours. PAI-1 was investigated by both Jung et al (1991) and Legnani et al (1993), 
however, neither research group reported any significant changes in this variable.    
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Increased tPA activity could explain the shortening of the euglobulin clot lysis time 
observed with garlic supplementation. However, it should also be realized that fibrinolytic 
potential has pronounced circadian variations (Angleton et al., 1988). PAI-1 activity and tPA 
antigen are significantly higher in the morning as compared to evening values (Angleton et al., 
1988). In contrast, tPA activity is significantly lower in the morning and inversely correlated (r=-
0.57) with PAI-1 activity (Angleton et al., 1988). Therefore, a portion of the impressive increases 
in tPA activity observed by these studies was due to normal diurnal variations rather than garlic 
supplementation. In support of this, tPA activity increased 35% and 31.4% in the placebo trials, 
in the Kiesewettier and colleagues (1991) and Jung and colleagues (1991) studies.  
It should also be noted that these studies had female participants (Kiesewetter et al., 
1990; Jung et al., 1991; Legnani et al., 1993) and participants who were active tobacco smokers 
(Jung et al., 1991; Legnani et al., 1993). Cederblad et al. (1977) and Giardina et al. (2004) have 
observed fibrinolytic activity to be variable across the menstrual cycle. None of the three studies 
indicated if they standardized their female participants’ treatment trials to menstrual cycle status. 
Research has also shown smoking tobacco alters fibrinolysis by decreasing tPA activity and 
antigen levels (Newby et al., 1999; Pretorius et al., 2002) and also by decreasing the tPA/PAI-1 
molar ratio (Barua et al., 2002). These two factors were controlled for in the present study. 
Fukao & colleagues (2007) uniquely examined the effects of garlic administration on 
markers in tPA and PAI-1 in vitro by using cultured human umbilical vein endothelial cells 
(HUVECs), fibrin film, and chromogenic assays. They observed that garlic preparations at the 
concentrations of 0.4 µg*mL-1, 100 µg*mL-1, 500 µg*mL-1, and 1 mg*mL-1 did not influence tPA 
or PAI-1 secretions from the HUVECs. However, when tPA was incubated with garlic on a fibrin 
film, the lysis area of fibrin increased 1.8x as a result of increased degradation of fibrin by tPA 
mediated activation of plasminogen. The assay also demonstrated increased plasmin generation 
by tPA in the presence of garlic.  Kinetic analysis showed that the maximum velocity achieved by 
the enzymatic system (Vmax) did not change but that the substrate concentration required to reach 
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half of Vmax decreased with garlic. The efficiency of the enzymatic reaction between tPA and 
plasminogen was also found to be enhanced which resulted in an 8.7x increase in total reactivity. 
Together these findings suggest garlic does not increase the secretion of tPA from the vascular 
endothelium but rather acts as a cofactor that increases the affinity between tPA and plasminogen. 
Harenberg and colleagues (1988) also conducted a unique study of the effects of garlic 
supplementation on fibrinoylsis. The researchers measured concentrations of fibrinopeptide Bβ 1-
42 in the blood following administration of 600 mg of dried garlic for 4 weeks in a group of 20 
out-patients with hyperlipoproteinemia. Fibrinopeptide Bβ1-42 is a product of the lysis of fibrin 
by plasmin (Nossel et al., 1979). Thus, the concentration of fibrinopeptide Bβ 1-42 in the blood is 
an indicator of the magnitude of fibrinolytic activation. Harenberg et al., (1988) observed a 10% 
and 42% increase in fibrinopeptide Bβ 1-42 concentration over baseline after 2 and 4 weeks of 
garlic administration, respectively.  These results suggest that fibrinolysis increases following 
garlic supplementation by enhancement of the activation of plasminogen.  Since tPA is the main 
activator of plasminogen, this study indirectly supports the hypotheses that garlic either increases 
the amount of enzymatically active tPA or acts as a cofactor that increases the affinity between 
tPA and plasminogen.   
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Table 2.1. The Effects of Garlic Supplementation on Fibrinolysis . 
Study Problem Participants Design Finding(s) 
Bordia 
et al. 
(1975) 
Effect of the essential 
oils of garlic on FA 
and fibrinogen 
10 healthy 
volunteers 
100 g of butter with 4 slices 
of bread  plus 50 g of garlic 
oil or placebo. 
↑ FA 15% 3 hr after 
garlic 
administration 
Bordia 
et al.  
(1977) 
Effect of essential oil 
of garlic on serum FA 
in patients with 
coronary artery disease 
I) 10 healthy 
individuals 
 
II) 10 patients 
with old 
myocardial 
infarction 
 
III) 20 patients 
with acute 
myocardial 
infarction 
Groups I and II administered 
1 g of the essential oil extract 
of raw garlic per kg of body 
weight per day for 3 mo.  
 
Group III administered 1 g of 
the essential oil extract of 
raw garlic per kg of body 
weight per day for 20 days.  
I) 
↑FA 130% by 3rd 
mo 
 
II) 
↑FA 83% by 3rd mo 
 
III) 
↑ FA 63% above 
post-infarction 
value after 10 d 
 
↑ FA 95.5% above 
post-infarction 
value after 20 d  
Bordia 
et al.  
(1978) 
The effect of essential 
oil of garlic on FA in 
patients of coronary 
artery disease. 
I) 20 Healthy 
volunteers 
 
II) 20 Patients 
with coronary 
artery disease 
The essential oil extract from 
1 g of raw garlic,  
administered daily for 3 mo.  
I) 
↑ FA 130% by 3rd 
mo 
 
II) 
↑FA 83% by 3rd mo 
Nossel 
et al. 
(1979 
Sequence of 
fibrinogen proteolysis 
10 female 
patients receiving 
an abortion  
Patients received intrauterine 
infusion of hypertonic saline  
Plasmin cleaves 
fibrinopeptide Bβ1-
42 from fibrin 
Arora 
et al. 
(1981) 
Effect of long-term 
garlic use on markers 
of ischemic heart 
disease 
I) 30 individuals 
with ischemic 
heart disease 
 
II) 20 healthy 
volunteers 
2 x 0.625 mg capsules, 
containing the essential oil of 
garlic, taken 3 times a day 
for 12 wk. 
↑ FA 52.4% and 
52.8% in both 
groups at 4th wk. 
 
↑ FA 26.5% and 
32.5% in both 
groups at 8th wk. 
 
↔ in FA above 
resting levels at 12th 
wk.  
FA= fibrinolytic activity (measured by euglobin clot lysis time), FPB β= Fibrinopeptide Bβ, tPA 
ACT= tissue plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, PAI-1= 
plasminogen activator inhibitor 1, HUVEC=human umbilical vein endothelial cells 
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Table 2.1. The Effects of Garlic Supplementation on Fibrinolysis (Continued). 
Study Problem Participants Design Finding(s) 
Chutani & 
Bordia 
(1981) 
Effect of fried versus raw 
garlic on FA in man 
I) 20 patients with 
ischemic heart disease 
 
II) 30 patients with 
ischemic heart disease  
I) A single dose 
of 0.5 g/kg body 
weight of raw or 
fried garlic.   
 
II) Raw or fried 
garlic pods 
administered in 
doses of 0.5 g/kg 
of body weight.   
I)  
↑FA 72% by 6 
and 12 h with 
raw garlic 
 
↑ FA 63% and 
66% by 6 and 
12 h 
respectively 
with fried garlic 
 
II)   
↑ FA 53% at 
end of first wk 
with raw garlic 
 
↑FA 84.8% by 
the end of 1 mo 
with raw garlic 
 
↑ FA 40% by 
the end of first 
wk with fried 
garlic 
 
↑ FA 72% by 
the end of 1 mo 
with fried garlic 
Bordia et 
al.  
(1982) 
The effect of garlic oil on FA 
and platelet adhesiveness in 
man 
I) 20 healthy 
volunteers 
 
II) 20 healthy 
volunteers 
I) 75 mg butter 
plus usual diet for 
3 wk 
 
II) 75 mg of 
butter plus 0.25 
mg/kg body 
weight of garlic 
oil for 3 wk.  
↑ FA 36.3% 
with a fatty diet 
and garlic oil 
by 3 wk. 
Luley et 
al. 
(1986) 
Effect of dried garlic on FA 
and fibrinogen levels 
51 hyperlipemic 
patients 
3 x 425 mg 
tablets, 
containing either 
a placebo or dried 
garlic 
↔ difference in 
FA observed 
 
Harenberg 
et al. 
(1988) 
Effect of dried garlic on 
blood coagulation, 
fibrinoylsis, and platelet 
aggregation in patients with 
hyperlipoproteinemia. 
20 out-patients with 
hyperlipoproteinemia. 
600 mg of dried 
garlic  pills, 3 x 
200 mg daily, for 
4 wk. 
↑ FpB β 1-24 
10% and 42% 
after 2nd and  4th 
wk, 
respectively 
FA= fibrinolytic activity (measured by euglobin clot lysis time), FPB β= Fibrinopeptide Bβ, tPA 
ACT= tissue plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, PAI-1= 
plasminogen activator inhibitor 1, HUVEC=human umbilical vein endothelial cells 
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Table 2.1. The Effects of Garlic Supplementation on Fibrinolysis (Continued). 
Study Problem Participants Design Finding(s) 
Kiesewettier 
et al. 
(1990) 
Effect of garlic on 
blood fluidity and FA 
10 healthy 
volunteers 
 100 mg, 300 mg, or 
600 mg of 
powdered garlic or 
placebo   
↑tPA ACT 56.3% in 
300 mg trial after 5 h 
 
↑ tPA ACT 51% in 
600 mg trial after 5 h 
Gadkari et 
al. 
(1991) 
 
 
 
Effect of raw garlic on 
FA and clotting time.  
I) 30 healthy 
medical students 
 
II) 20 healthy 
medical students 
10 g of raw garlic 
for 2 mo. 
↑FA 21.8% in group I 
by 2 mo.  
 
Jung et al. 
(1991) 
Effect of garlic powder 
on cutaneous 
microcirculation 
10 healthy 
volunteers 
3 x 300 mg of pure 
garlic powder 
capsules or 3 x 300 
mg of placebo 
↑ tPA ACT 86.1% 
after 5 h 
 
Legnani et 
al. 
(1993) 
Effect of dried garlic on 
fibrinolysis and platelet 
aggregation in healthy 
subjects. 
10 healthy 
volunteers 
900 mg of dried 
garlic powder  
↔ difference in tPA 
ACT or tPA AG after 
2, 4, or 6 h 
  
Bordia et al. 
(1998) 
Effect of Darlic on 
Fibrinolytic and 
Fibrinogen in patients 
with CAD 
I)30 patients with 
CAD 
 
II)30 patients with 
CAD 
I) 2x2 capsules 
containing 1 g of 
raw garlic 
 
II) 2x2 capsules 
containing placebo  
I)  
↑ FA 39.4% and 
55.1% by 1.5 and 3 
mo, respectively 
 
↔ in fibrinogen levels 
 
II) ↔ in all measures 
Fukao et al. 
(2007) 
Antithrombotic effects 
of odorless garlic 
powder in vitro 
24-well 
multiplates with 
seeded human 
umbilical vein 
endothelial cells 
 
Fibrin film assay 
 
 
HUVECs cultured 
with garlic powder 
at 37°C for 18 h  
 
Fibrin film plate 
with fibrinogen, 
thrombin, 
plasminogen, tPA 
and garlic  
↔ in release of tPA or 
PAI-1 from HUVECs 
 
↑1.8x in tPA ACT on 
fibrin plate in the 
presence of garlic 
 
↑8.7x increase in 
efficacy of enzyme 
reaction between tPA 
and plasminogen in 
the presence of garlic  
FA= fibrinolytic activity (measured by euglobin clot lysis time), FPB β= Fibrinopeptide Bβ, tPA 
ACT= tissue plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, PAI-1= 
plasminogen activator inhibitor 1, HUVEC=human umbilical vein endothelial cells 
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The Effects of Acute Exercise on Fibrinolytic Potential 
Exercise accelerates fibrinolytic activity (Davis et al., 1979, Wheeler et al., 1986, Drygas 
1988, El-Sayed 1990). This acceleration is primarily attributed to elevations in tPA (El-Sayed, 
1990). The magnitude of the increase in tPA is dependent upon both the exercise intensity and 
duration. A study by Hansen et al. (1990) observed fibrinolytic responses to seven healthy male 
volunteers who ran 1.7 km, 4.8 km, and long 10.5 km distances at speeds close to their maximal 
capacity.  tPA antigen levels rose substantially across all trials, but, the greatest response occurred 
in the 10.5 km run, with the 4.8 km run eliciting the second greatest response. A study by Van 
Den Burg et al. (1997) also demonstrated the influence of duration. In this study, 20 healthy men 
cycled at 70% of VO2max for 25 minutes followed by a graded test to volitional exhaustion. 
During the 25 minutes of steady state cycling there was a linear rise in tPA ACT and tPA AG. 
However, at the onset of the graded exercise test to maximal exhaustion there was a dramatic 
increase in tPA ACT and tPA AG. Although the separate influence of duration on fibrinolytic 
activity is important, the primary determent is intensity of exercise. A study by Womack & 
colleagues (2006) best demonstrates this principle. In their study they observed that tPA activity 
and tPA antigen were significantly higher following 20 minutes of exercise above lactate 
threshold (LT) as compared to an isocaloric, longer duration exercise test below LT. Similarly, 
Weiss et al. (1998) observed about a 3x larger increase in tPA antigen after a 1 hour run at 83% 
VO2max as compared to after a 1 hour run at 68% VO2max.  
The mechanisms for the exercise-induced increases in tPA are not completely understood 
and numerous factors have been proposed to be responsible for the exercise-induced increases in 
tPA.  One of the most strongly cited mechanisms is increased adrenergic stimulation. Chandler 
and colleagues (1992) observed that the time course and dose response of tPA release was similar 
for epinephrine infusion and exercise. However, the absolute rate of increase of tPA versus 
epinephrine concentration was 2x as fast during exercise as with infusion. This lead Chandler and 
colleagues to attribute approximately 50% of the increase in tPA directly to increased levels of 
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epinephrine. Yet if epinephrine only accounts for 50% of the observed increases in tPA, then 
there must be at least one other mechanisms to contribute to the remaining 50%. A second 
potential mechanism is vasopressin. Vasopressin itself stimulates the fibrinolytic system 
(Hariman et al., 1989) and there is a rise in plasma levels of vasopressin during exercise (El-
Sayed et al., 1990). However, there is no correlation between the exercise induced rise in 
vasopressin and the exercise induced rise in fibrinolysis (El-Sayed, 1990). A third commonly 
cited mechanism is changes in blood lactate. Wheeler and colleagues (1986) observed a strong 
correlation (r=0.81, P< 0.001) between postexercise fibrinolytic activity and postexercise blood 
lactate concentrations. However, eight minutes after exercise lactate levels continued to rise but 
fibrinolytic activity decreased rapidly. Similarly, Drygas (1988) demonstrated that 60 minutes of 
submaximal exercise could increase fibrinolytic activity without changing blood pH. A fourth 
potential mechanism may be diminished hepatic clearance. Clearance of tPA is achieved through 
the mannose receptor located on hepatic endothelial cells and a low-density lipoprotein receptor-
related protein that is a hepatic receptor for both free tPA and the inactive tPA/PAI-1 complex 
(Narita et al., 1995). Blood flow to the liver is reduced during exercise, which in turn decreases 
hepatic clearance (Bounameaux et al., 1986; De Boer et al., 1992). This may allow for the 
accumulation of tPA in the blood during exercise. Research by Hersch et al. (1987) supports this 
theory as they observed elevated tPA levels in patients with decreased clearance due to liver 
cirrhosis. 
At the termination of exercise tPA levels begin to rapidly decline (Davis et al., 1976). 
tPA remains only slightly elevated above base line within 30 minutes after exercise (Hansen et 
al., 1990; Van Den Burg et al., 1995). By one hour post-exercise there is no longer any 
enhancement of the fibrinolytic system (Paton et al., 2004; Womack et al., 2006). Cooper et al. 
(2004) examined the time course changes of tPA after acute maximal exercise in eight healthy 
men. Blood samples were collected before exercise and at 1, 2, 4, 5, 6, and 10 minutes post 
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exercise. It was observed that plasma tPA activity and antigen reached had significantly declined 
within four minutes after exercise.  
PAI-1 has been shown to decrease with exercise by some (Paton et al., 2004; Womack et 
al., 2006) and to remain unchanged with exercise by others (Hilberg et al., 2003). The response 
by PAI-1 has also been shown to vary within the same study depending upon if PAI-1 activity or 
PAI-1 antigen was being examined (Hilberg et al. 2003; Womack et al., 2006). This suggests that 
PAI-1 is not appreciably altered by exercise. Moreover, statistical power calculations performed 
by Cooper & colleagues (2004) reveal that at least 37 participants are necessary to yield a 
statistical power of 0.80 for PAI-1 activity. Since most of the studies examining the effect of 
exercise on PAI-1 had a participant pool of <37 they lacked sufficient statistical power to 
properly examine PAI-1. 
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Table 2.2.: The Effects of Acute Exercise on Fibrinolytic Potential 
Study Problem Participants Design Finding(s) 
Davis et al. 
(1976) 
Fibrinolytic 
changes during 
and after 
maximal 
exercise 
10 healthy males Subjects performed a 
graded exercise test to 
physical exhaustion 
↑FA ≈175% 
immediately post-
maximal exercise 
 
↔ FA at 
intensities <50-
60% MHR 
 
↑FA 
exponentially at 
intensities >60-
70% MHR 
Wheeler et al. 
(1986) 
Changes in 
hemostatsis 
associated with 
acute exercise 
19 healthy males Subjects performed a 
branching multistage 
treadmill protocol to 
maximum 
↑ FA 505% 
postexercise 
 
↓ FA 25% from 
postexercise value 
8 min post-
exercise 
 
Postexercise FA 
∝ postexercise 
blood lactate, 
r=0.81 
Hersch et al. 
(1987) 
Pathogenesis of 
accelerated 
fibrinolysis in 
liver cirrhosis 
30 liver cirrhosis 
patients  
Blood samples of 30 
liver cirrhosis patients 
were taken 
↑tPA AG ≈428% 
in patients with 
liver cirrhosis  
Hamouratidis et 
al. 
(1988) 
Effect of 
exercise on 
plasma 
fibrinolytic 
activity in 
healthy males 
30 healthy males Exercise testing on a 
treadmill according to 
the Bruce protocol 
↓ 51% euglobulin 
clot lysis time in 
healthy men post-
exercise 
FA= fibrinolytic activity, MHR= maximum heart rate, tPA AG= tissue plasminogen activator 
antigen 
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Table 2.2: Effects of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Drygas 
(1988) 
Changes in FA in 
response to 
moderate, 
exhaustive, and 
prolonged exercise 
47 healthy men Subjects 
performed 
isometric exercise, 
18 min of 
submaximal 
exercise, 60 min of 
submaximal 
exercise, and 
repeated 60 s bouts 
of maximal 
exercise 
↔ in FA with 
isometric exercise 
 
↑ FA 25% after 18 
min of submaximal 
exercise 
 
↑ FA 58% after 60 
min of submaximal 
exercise 
 
↑63% after 
maximal bouts of 
exercise 
 
↔ in pH with 
isometric or 60 
min of submaximal 
exercise 
 
↓ pH 0.5% and 2% 
with 18 min of 
submaximal 
exercise and 
repeated maximal 
exercise, 
respectively  
Hariman et al.,  
(1989) 
Physiological 
concentrations of 
vasopressin on the 
fibrinolytic system 
9 male volunteers Infusion of saline 
for 30 min 
followed by 
infusion with 
vasopressin for 1 
hour 
↑ tPA ACT ≈28x 
60 min post-
infusion 
 
↓ PAI-1 ACT 
≈19% 60 min post-
infusion 
FA= fibrinolytic activity, tPA ACT= tissue-type plasminogen activator activity,  PAI-1 
ACT=plasminogen activator inhibitor activity 
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Table 2.2. Effects of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
El-
Sayed 
(1990) 
Exercise intensity 
related responses of 
fibrinolysis and 
vasopressin 
16 normal 
healthy subjects 
Subjects cycled at 40%, 
70% and 100% of 
VO2max 
No correlation between 
exercise-induced 
changes in FA and 
vasopressin 
 
↑ in FA in response to 
exercise is directly 
related to fractional 
workload (%VO2max) 
 
↑ in exercise-related 
FA is mainly due to 
elevated tPA levels 
Hansen 
et al. 
(1990) 
Procoagulant and 
fibrinolytic activities 
in circulation after 
strenuous physical 
exercise 
7 healthy 
recreationally 
active men 
Subjects participated in 
short (1.7km), middle (4.8 
Km) and long (10.5 km) 
runs at a speed close to 
their maximal capacity 
↑≈ 300%, 200%, 180% 
in tPA AG at long, 
middle, and short 
distances respectively 
 
tPA AG ↓ to baseline 
by 30 min post-
exercise 
De 
Boer et 
al. 
(1992) 
Liver Blood Flow as a 
Determinant of tPA 
Clearance 
6 healthy males 
 
8 male Wistar 
rats 
Subjects performed a 
submaximal exercise test 
while receiving an 
infusion of ICG and rtPA 
 
Rat liver perfused through 
portal vein with rtPA at 
different flow rates 
↑rTPA ACT and AG 
119% and 91% 
respectively during 
exercise 
 
↑ICG 133% during 
exercise 
 
↓liver blood flow 53% 
during exercise 
 
Live blood flow 
returned to normal 25 
min post-exercise 
 
Halving or doubling 
flow rate of perfused 
rate liver causes 
proportional changes 
in rtPA clearance 
FA= fibrinolytic activity, tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue 
plasminogen activator antigen, PAI-1 ACT=plasminogen activator inhibitor activity, ICG= 
tricarboycyanine dye indocyanine green,  
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Table 2.2. Effects of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Chandler et al. 
(1992) 
Fibrinolytic 
response during 
exercise and 
epinephrine 
infusion in the 
same subjects 
14 healthy men Participants were 
studied during 
epinephrine infusion 
and graded supine 
bicycle exercise to 
exhaustion.   
↑388% tPA ACT  
at point of 
exhaustion over 
baseline 
 
↑PAI-1 ACT 24% 
at point of 
exhaustion over 
baseline 
 
↑ 218%  tPA 
ACT at maximal 
epinephrine 
infusion rate over 
baseline 
 
↔ in PAI-1 or 
tPA/PAI-1 
complex during 
infusion 
 
Linear 
relationship 
between tPA and 
epinephrine levels 
observed 
 tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator 
antigen, PAI-1 ACT=plasminogen activator inhibitor activity 
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Table 2.2. Effects of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Szymanski & 
Pate 
(1994) 
Fibrinolytic 
responses to 
moderate 
exercise in 
physically active 
and inactive men 
 
Fibrinolytic 
responses during 
morning and 
evening exercise 
I) 14 inactive men 
 
II) 12 active men 
Two 30 minute 
submaximal exercise 
sessions at 50% of 
VO2max 
↑ tPA ACT ≈71% 
with evening 
exercise in active 
group 
 
↑tPA ACT ≈28% 
with morning 
exercise in active 
group 
 
↑ tPA ACT ≈25% 
with evening 
exercise in 
inactive group 
 
↑tPA ACT ≈8% 
with morning 
exercise in 
inactive group  
 
↔ in PAI-1 ACT 
with exercise in 
either group at 
either time point 
Van Den Burg 
et al. 
(1995) 
Haemostatic 
changes 
following 
strenuous 
physical exercise 
29 healthy 
sedentary men 
Exercise test consisted 
of 4 phases on a cycle 
ergometer: 1) 25 
minutes of cycling at 
70% VO2max 2) graded 
cycling to VO2max, 
3)10 min of active 
recover, 4) 15 minutes 
of passive recovery  
↑183% tPA AG at 
maximal exercise 
 
↑tPA ACT 892% 
at maximal 
exercise  
 
↓tPA ACT 61% 
from maximal 
exercise value by 
25 min of 
recovery 
 
↓ tPA ACT 42% 
from maximal 
exercise value by 
25 min of 
recovery  
 
Coagulant and 
fibrinolytic 
activity during 
submaximal 
exercise  are  = up 
to 70% VO2max  
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, 
PAI-1 ACT=plasminogen activator inhibitor activity  
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Table 2.2. The Effects of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Szymanski et al. 
(1996) 
Factors affecting 
fibrinolytic 
potential 
46 healthy white 
men 
Maximal graded 
exercise tests on a 
treadmill  
↑217% in tPA 
ACT, ↓31% PAI-
1 ACT following 
maximal exercise 
Van Den Burg 
et al. 
(1997) 
Effect of 
endurance 
training on 
seasonal 
fluctuations on 
coagulation and 
fibrinolysis 
 20 healthy 
sedentary men 
Exercise tests were 
performed in 4 phases 
on a cycle ergometer: 1) 
25 minutes of cycling at 
70% VO2max, 2) 
graded cycling to 
VO2max, 3)10 min of 
active recovery, 4 15 
minutes of passive 
recovery. 
tPA ACT and tPA 
AG ↑ linearly 
with time during 
submaximal 
exercise 
 
tPA ACT and tPA 
AG↑ 
exponentially 
during graded 
exercise tests  
Weiss et al. 
(1998) 
Coagulation and 
fibrinolysis after 
moderate and 
very heavy 
exercise 
12 young men Two treadmill tests at 
68% and 83% VO2max 
for 1 h 
↑tPA AG ≈300% 
and ≈380% after 
30 min and 60 
min  of running at 
83% VO2max 
 
↑tPA AG 100% 
and 160% after 30 
min and 60 min  
of running at 68% 
VO2max 
 
↓ tPA AG to base 
line 1 h post-83% 
VO2max run 
 
Fibrinolytic 
system ↑to a 
higher degree 
during heavy 
exercise than the 
coagulant system 
 
Fibrinolytic 
potential ↓ at  
faster rate than 
coagulation 
potential post-
exercise  
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, 
PAI-1 ACT=plasminogen activator inhibitor 
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Table 2.2. The Effects of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Hedge et al. 
(2000) 
Changes in 
clotting and 
fibrinolytic 
activity during 
the 1 h after a 
submaximal run 
10 healthy males Subjects completed two 
treadmill tests at either 
70-75% VO2max or at 
1.2 mph for 30 minutes 
each.  
↑200% tPA ACT 
after 30 min of 
running  
 
↓ tPA ACT 33%, 
44%, and 49% 20 
min, 40 min, and 
60 min post-
exercise 
Hilberg et al. 
(2003) 
Blood 
coagulation and 
fibrinolysis after 
extreme short-
term exercise 
15 healthy trained 
males 
Three maximal cycle 
ergometer tests with 
duration of 15, 45, and 
90s and a control day 
without an exercise 
↑ tPA AG 83%, 
149%, and 293% 
after 15s, 45s, and 
90s respectively 
 
Changes in tPA 
AG returned to 
baseline 1 h post-
exercise 
Hilberg et al. 
(2003) 
Blood 
coagulation and 
fibrinolysis after 
long duration 
treadmill 
exercise 
controlled by 
anaerobic 
threshold 
16 healthy males Treadmill ergometer 
test at intensity of 90% 
of individual anaerobic 
threshold lasting 60-120 
min 
↑ tPA ACT 32% 
post exercise over 
baseline 
 
↓ tPA ACT to 
baseline value 2 h 
post-exercise 
 
↑tPA AG 737% 
immediately post 
exercise  
 
↓ tPA AG 82% 2 
h post-exercise 
from initial post-
exercise value  
 
↓PAI-1 ACT 69% 
post-exercise. 
 
↑ PAI-1 AG 26% 
2 h post-exercise 
over post-exercise 
value 
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, 
PAI-1 ACT=plasminogen activator inhibitor 
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Table 2.2.The  Effect of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Womack et al. 
(2003) 
Coagulation and 
Fibrinolytic 
Response to 
Manual vs 
Automated 
Snow Removal 
13 health male 
subjects 
Subjects performed a 
maximal ramped 
treadmill test, shoved a 
driveway clear of snow, 
and removed snow from 
a driveway with an 
automated snow 
thrower 
↑tPA AG 227% 
immediately post-
exercise with 
treadmill test 
 
↓PAI-1 31% 
immediately post-
exercise with 
treadmill test 
Cooper et al. 
(2004) 
Temporal 
changers in tPA 
and PAI-1 after 
maximal 
exercise 
8 healthy males Subjects performed a 
graded exercise test to 
volitional exhaustion on 
a treadmill 
↑ tPA ACT 19x 
from baseline to 
post-exercise 
 
↑tPA AG 5x from 
baseline to post-
exercise 
 
↓PAI -1 ACT 
≈55% from 
baseline to post-
exercise 
Paton et al. 
(2004) 
Changes in von 
Willebrand 
factor and 
fibrinolysis 
following a post-
exercise cool-
down 
10 healthy males Subjects performed two 
maximal treadmill tests. 
Each test was followed 
by either an active cool 
down or a passive cool 
down 
↑ tPA ACT and 
tPA AG ≈15x and 
≈4x respectively 
 
Fibrinolytic 
potential returned 
to baseline 1 h 
post exercise 
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, 
PAI-1 ACT=plasminogen activator inhibitor 
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Table 2.2.The  Effect of Acute Exercise on Fibrinolytic Potential (Continued). 
Study Problem Participants Design Finding(s) 
Womack et al. 
(2006) 
Changes in 
fibrinolysis 
following 
exercise above 
and below 
lactate threshold 
15 healthy males Subjects performed 
cycle ergometry tests 
>LT threshold and 
equicaloric cycle 
ergometry <LT 
↑tPA ACT 145% 
in the >LT trial  
 
↑tPA AG  71% 
and 22% in the 
>LT and <LT 
trials 
 
Post-exercise tPA 
AG 37% higher 
in >LT trial 
 
↓PAI-1 ACT 
33% and 13 % in 
both the >LT and 
<LT trials 
 
↔ changes in 
tPA or PAI-1 
levels 1 h post-
exercise 
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, 
PAI-1 ACT=plasminogen activator inhibitor, LT= lactate threshold 
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The Effects of Acute Exercise on Coagulation Potential 
 Exercise induces a hypercoagulant state (Davis et al., 1976; Wheeler et al., 1986; El-
Sayed, 1993; Hedge et al., 2001).  As with fibrinolytic activity, markers of coagulation rise 
substantially after the onset of exercise (Davis et al., 1976; Wheeler et al., 1986; Hansen et al., 
1990; Van Den Burg et al., 1995; Van Den Burg et al., 1997). This rise in coagulation activity 
parallels the aforementioned rise in fibrinolytic potential up to 70% VO2max (Van Den Burg et 
al., 1995). At higher intensities there is an even more pronounced increase in fibrinolytic potential 
that exceeds the increase in coagulant activity (Van Den Burg et al., 1995; Weiss et al., 1998). 
This suggests a reduced thrombotic tendency at these higher intensities. 
 Post-exercise there is a marked difference in the coagulant response as compared to the 
fibrinolytic response. As mentioned in the previous section, there is an immediate decrease in 
firbinolysis post-exercise with values rapidly returning to baseline (Weiss et al., 1998). However, 
with coagulant activity, markers either persistently rise (Wheeler et al., 1986, Weiss et al., 1997; 
Van Den Burg et al., 1997; Hilberg et al., 2003), remain elevated (Hedge et al., 2000; Paton et al., 
2004), or decline slowly with levels remaining significantly elevated above baseline up to 10 
hours later (Hansen et al., 1990).  
 The mechanisms responsible for the exercise-induced increase in coagulant activity are 
not fully understood. This is inherently due to the intricate nature of the coagulation cascade 
itself. However, some mechanisms may be described, albeit not fully. The increase in clotting 
activity, as measured by a fall in the activated partial thromboplastin time (aPPT), can be 
attributed to an increase in FVIII activity. Hedge et al. (2000) examined the clotting activity 
during the hour after a submaximal run at 70-75% VO2max in 10 healthy men and observed that 
aPPT decreased by approximately 2 seconds and remained shortened during the entire 1 hour 
recovery period. They also observed that this shortening in aPTT was significantly correlated (r=-
0.7) to increases in FVIII activity. Yet, the mechanism(s) for the increased FVIII activity are not 
fully understood. Since FVIII is composed to two proteins, factor VIII:C and Von Willebrand 
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Factor (vWF), vWF can be used to elucidate changes in coagulation potential as well. Von Kanel 
et al. (2003) demonstrated that beta-adrenergic stimulation and blockade respectively increases 
and inhibits the release of vWF from endothelial cells. Since exercise produces substantial 
elevations in epinephrine (Chandler et al., 1992), perhaps increased concentrations of 
catecholamines is the mechanism for enhanced coagulant activity. However, this is unlikely to be 
a lone mechanism as catecholamines do not display a continual increase post-exercise (Dimsdale 
et al., 1984). Another proposed mechanism is reduced hepatic blood flow.  FVIII is cleared at the 
liver by a low-density lipoprotein-related receptor (Saenko et al., 1999). Paton et al. (2004) 
examined changes in vWF following a post-exercise cool-down in 10 healthy men. They 
observed that an active cool-down resulted in reduced levels of vWF post-cool down and 1 hour 
post-exercise. Since active cool-downs are used to prevent venous pooling and improve venous 
returns, this may suggest that hepatic clearance can play a role.  However, hepatic blood flow 
returns to normal levels rapidly post-exercise (De Boer et al., 1992). Therefore, it seems unlikely 
that reduced hepatic clearance is a primary cause of the persistent coagulant activity post-
exercise. Additional proposed hypotheses include the neogenesis of FVIII from the vascular 
endothelium (El-Sayed, 1993), increased thrombin activation (El-Sayed, 1993), and lactic 
acidosis (Crowell & Houston, 1961). Clearly future research is needed to elucidate the exact 
mechanisms of the exercise-induced enhancement in coagulant activity.  
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential. 
Study Problem Participants Design Finding(s) 
Crowell & 
Houston 
(1961) 
Effect of acidity 
on blood 
coagulation 
15 dogs Samples of heparinized 
blood had their pH 
altered, ranging from 
6.0-7.4, via the addition 
of lactic acid to the 
sample 
Lowering the pH 
of heparinized 
blood to ≈6.7 
reduced clotting 
time  
Davis et al. 
(1976) 
Fibrinolytic 
changes during 
and after 
maximal 
exercise 
10 healthy males Subjects performed a 
graded exercise test to 
physical exhaustion 
↔ FVIII at 
intensities <60-
70% MHR 
 
↑FVIII 
exponentially at 
intensities >70% 
MHR 
 
Peak ↑FVIII, 
125%, occurred 5 
min post-exercise 
Dimsdale et al. 
(1984) 
Changes in 
catecholamines 
postexercise 
10 healthy males Subjects performed a 
graded exercise test to 
exhaustion 
↑ NEPI and EPI 
≈880% and 
≈241% 3 minutes 
post-exercise, 
respectively 
 
↓NEPI and EPI 
≈48% ≈36% from 
3 min value by 6 
min 
Wheeler et al. 
(1986) 
Pyhsiological 
changes in 
hemostasis 
associated with 
acute exercises 
19 health male 
subjects 
Subjects performed a 
branching multistage 
treadmill protocol to 
maximum 
↑FVIII activity 
≈180% post-
exercise 
 
↑FVIII activity 
≈300% 8 min 
post-exercise as 
compared 
baseline value 
 F VIII= Factor VIII,  FVIII= Factor VIII, NEPI= norepinephrine, EPI= epinephrine  
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Table 2.3 The Effect s of Acute Exercise on Coagulation Potential (Continued) 
Study Problem Participants Design Finding(s) 
Hansen 
et al. 
(1990) 
Procoagulant and 
fibrinolytic 
activities in 
circulation after 
strenuous physical 
exercise 
7 healthy 
recreationally 
active men 
Subjects participated in short 
(1.7km), middle (4.8 Km) 
and long (10.5 km) runs at a 
speed close to their maximal 
capacity 
↑vWF 194%, 95.9%, 
95.9% in short, 
middle, and long 
runs, respectively, 
immediately post-
exercise 
 
vWF remained 
≈30%, 60%, and 80% 
elevated in short, 
middle, and long runs 
10 h after exercise 
El-Sayed 
(1993) 
Hemostatic 
responses after 
resistance exercise 
Seven healthy 
subjects 
Subjects performed 3 
exercise sessions: low 
volume resistance exercises 
at 90-100% 1RM, high 
volume resistance exercises 
at 70-80% 1RM, or no 
exercise control  
↑ FVIII 100% post 
low volume 
resistance exercise 
 
↑FVIII 160% post 
high volume 
resistance exercise 
Van Den 
Burg et 
al. 
(1995) 
Haemostatic 
changes following 
strenuous physical 
exercise 
29 healthy 
sedentary men 
Exercise test consisted of 4 
phases on a cycle ergometer: 
1) 25 minutes of cycling at 
70% VO2max 2) graded 
cycling to VO2max, 3)10 
min of active recover, 4) 15 
minutes of passive recovery 
 
Coagulant and 
fibrinolytic activity 
during submaximal 
exercise  are  = up to 
70% VO2max 
↑ FVIII, FXII, FIX, 
and FVII 80%, 10%, 
17%, and 4% over 
baseline at maximal 
exercise 
 
↑Factor VIII 148% 
over baseline 25 min 
following maximal 
exercise 
 
↓aPTT 15% over 
baseline at maximal 
exercise 
 
↓aPTT16.3% over 
baseline 25 min 
following maximal 
exercise 
vWF=von Willebrand factor, aPTT= Activated partial thromboplastin time, F VIII= Factor 
VIIIFVIII= Factor VIII, FXII= Factor XII, FIX= Factor IX, and, FVII= Factor VII, 
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Table 2.3 The Effects of Acute Exercise on Coagulation Potential (Continued) 
Study Problem Participants Design Finding(s) 
Van Den Burg 
et al. 
(1997) 
Effect of 
endurance 
training on 
seasonal 
fluctuations on 
coagulation and 
fibrinolysis 
 20 healthy 
sedentary men 
Exercise test consisted of 
4 phases on a cycle 
ergometer: 1) 25 minutes 
of cycling at 70% 
VO2max 2) graded 
cycling to VO2max, 3)10 
min of active recover, 4) 
15 minutes of passive 
recover 
↑ FVIII ≈100% 
and ≈126% 
immediately 
following 
maximal exercise 
and 25 min 
following 
maximal exercise, 
respectively 
 
↓aPTT ≈14% and 
remained ↓to this 
extent 25 min 
later 
 F VIII= Factor VIII, aPTT= Activated partial thromboplastin time 
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued). 
Study Problem Participants Design Finding(s) 
Weiss et al. 
(1998)  
Coagulation and 
fibrinolysis after 
moderate and very 
heavy exercise 
12 young men Two treadmill tests 
at 68% and 83% 
VO2max for 1 h 
↑FPA ≈100%, and 
≈155% over 
baseline after 30 
and 
60 min of running 
at 83% VO2max 
run 
  
↑FPA ≈144% over 
baseline 1 h post-
83% VO2max run 
 
↑TAT ≈87% over 
baseline after 60 
min of running at 
83% VO2max  
 
↑TAT 47% over 
baseline 1 h post-
83% VO2max run 
 
↓aPTT 8% and 
13% from baseline 
30 and 60 min 
post-83% VO2max 
run 
 
↓aPTT 11% from 
baseline 1 h post-
83% VO2max run 
 
Fibrinolytic system 
↑ to a higher degree 
during heavy 
exercise than the 
coagulant system 
 
Fibrinolytic 
potential ↓ at  faster 
rate than 
coagulation 
potential post-
exercise period 
Saenko et al., 
(1999) 
Catabolism of 
factor VIII by LPR 
Cultured mouse 
embryonic 
fibroblasts 
Cell-mediate ligand 
internalization and 
degradation assays 
FVIII specifically 
binds to LPR  
 
LPR mediates 
internalization and 
degradation of 
FVIII 
aPTT= Activated partial thromboplastin time, TAT= Thrombin Antithrombin III Complex, FPA= 
Fibrinopeptide A, LPR= Low density lipoprotein receptor-related protein 
Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued). 
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued). 
Study Problem Participants Design Finding(s) 
Hedge et al. 
(2000) 
Changes in clotting 
and fibrinolytic 
activity during the 
1 h after a 
submaximal run 
10 healthy males Subjects 
completed two 
treadmill tests at 
either 70-75% 
VO2max or at 1.2 
mph for 30 
minutes each.  
↑ FVIII ≈40% after 
30 min of running  
 
FVIII remained 
≈40% elevated 1 h 
post-exercise  
 
↓8% in aPTT 
immediately after 
submaximal run 
showed significant 
negative 
correlation (r=-0.7)  
with  ↑ in FVIII 
Von Kanel et al. 
(2000) 
Effects of  
nonspecific β-
adrenergic 
stimulation and 
blockade on blood 
coagulation in 
hypertension 
I) 15 hypertensive 
subjects and 21 
normotensive 
subjects 
 
II) 13 member 
subgroup (3 
hypertensives) 
I) Subjects 
received 
isoproternol 
infusion 
 
II) Subjects were 
studied twice, once 
after 5 days of 
placebo treat and 
once after 5 days 
of 100 mg/day of 
propranolol 
 
Isoproternol 
infusion led to ↑ in 
plasma vWF 
across all subjects. 
 
Propranolol 
completely 
abolished the ↑ in 
wVF elicited by 
isoproternol 
Hilberg et al. 
(2003) 
Blood coagulation 
and fibrinolysis 
after extreme 
short-term exercise 
15 healthy trained 
males 
Three maximal 
cycle ergometer 
tests with duration 
of 15, 45, and 90s 
and a control day 
without an exercise 
↓ aPTT 10%, 17%, 
and 20% after15s, 
45s, and 90s.  
 
Changes in aPTT 
not fully reversed 
after 1 h 
 
↑ TAT 53% 
immediately post-
exercise 
 
Remained elevated 
2 h post-exercise 
 
↑F1+2 34% 
immediately post 
exercise 
vWF=von Willebrand factor, aPTT= Activated partial thromboplastin time, F1+2= Prothrombin 
Fragment,  FVIII= Factor VIII,  
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued). 
Study Problem Participants Design Finding(s) 
Hilberg et al. 
(2003) 
Blood 
coagulation and 
fibrinolysis after 
long duration 
treadmill exercise 
controlled by 
anaerobic 
threshold 
16 healthy males Treadmill ergometer test 
at intensity of 90% of 
individual anaerobic 
threshold lasting 60-120 
min 
↓aPTT 14% and 
11%  
immediately post-
exercise and 2 h 
post-exercise, 
respectively, as 
compared to 
baseline  
 
↑ TAT 53% 
immediately post-
exercise 
 
↑F1+2 34% and 
16%  
immediately post 
exercise and 2 h 
post-exercise 
respectively 
Paton et al. 
(2004) 
Changes in von 
Willebrand factor 
and fibrinolysis 
following a post-
exercise cool-
down 
10 healthy males Subjects performed two 
maximal treadmill tests. 
Each test was followed 
by either an active cool 
down or a passive cool 
down 
↑vWF:  ≈ 120% 
and ≈88% post-
cooldown and 1 h 
post-exercise, 
respectively, as 
compared to 
baseline 
Womack et al. 
(2003) 
Coagulation and 
Fibrinolytic 
Response to 
Manual vs 
Automated Snow 
Removal 
13 health male 
subjects 
Subjects performed a 
maximal ramped 
treadmill test, shoved a 
driveway clear of snow, 
and removed snow from 
a driveway with an 
automated snow thrower 
↑vWF 76% 
immediately post-
exercise with 
treadmill test 
vWF=von Willebrand factor, aPTT= Activated partial thromboplastin time, F1+2= Prothrombin 
Fragment, TAT= Thrombin Antithrombin III Complex 
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Methodological Considerations for Fibrinolytic Research 
Participants are an important methodological consideration for conducting research 
involving fibrinolysis. Research has shown that activation of the fibrinolytic system varies across 
the menstrual cycle (Cederblad et al., 1977; Giardina et al., 2004). Therefore, one either needs to 
avoid using female participants or control for differences in the menstrual cycle status. The 
physical activity status of the participants also needs to be taken under consideration. Physically 
active men tend to have lower resting PAI-1 values and slightly higher tPA activity values post-
exercise as compared to physically inactive men (Symanski & Pate, 1994). 
 A second point to consider is time of day. There are significant circadian variations in the 
fibrinolytic system (Angleton et al., 1988).  PAI-1 activity and tPA antigen are highest in the 
morning compared to the evening. In contrast, tPA activity is lowest in the morning and highest 
in the evening. The fibrinolytic response to physical activity is also influenced by time of day as 
physical activity in the evening elicits a substantially greater fibrinolytic response than physical 
activity in the morning (Symanski & Pate, 1994). Therefore, to avoid time day confounding the 
data, it is necessary have each of a participant’s treatment trials occur at the same time of day. 
 Posture must also be standardized when conducting experiments involving fibrinolytic 
potential. Winther & colleagues (1992) examined the effects of posture on fibrinolytic potential in 
12 healthy men. Participants went from the supine to upright posture, the upright to supine 
posture, and the supine to upright posture across the time course of a morning. Participants held 
the remained in the new posture after each switch for 90 minutes. Significant variations in tPA 
antigen levels were noticed 10 minutes following the supine to upright and upright to supine 
posture shifts. No statistical differences were seen in either postural shift after the new posture 
had been assumed for the next time point (90 minutes). This suggests that when evaluating tPA 
antigen levels, it is necessary to control for postural effects by standardizing pre-trial positions for 
a minimum of greater than 10 minutes. 
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 The timing of post-exercise blood sampling is also an important methodological 
consideration as the half-life of tPA is approximately 3 minutes (Korninger et al., 1981; Nilsson 
et al., 1984) and fibrinolytic activity declines  post-exercise have been noted in as little as 5 
minutes (Davis et al., 1976). A study by Cooper et al. (2004) examined the temporal changes in 
tPA and PAI-1 after maximal exercise. tPA activity did not change from 1 to 2 minutes post-
exercise but decreased significantly by 4 minutes post-exercise. They also observed PAI-1 
decrease from pre to post-exercise but PAI-1 values did not change during 10 minutes post-
exercise. This suggests that to accurately assess the tPA response to acute exercise, blood samples 
need to be collected within 2 minutes after the cessation of exercise. 
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Table 2.4. Methodological Considerations for Fibrinolytic Research 
Study Problem Participants Design Finding(s) 
Davis et al. 
(1976) 
Fibrinolytic 
changes during 
and after maximal 
exercise 
10 healthy males Subjects performed 
a graded exercise 
test to physical 
exhaustion 
↓FA ≈15% from 
post-exercise 
maximum by 5 
min post-exercise 
Cederblad et al. 
(1977) 
Variations in 
blood coagulation 
and fibrinolysis 
across the 
menstrual cycle 
30 normal women Blood samples 
collected across the 
menstrual cycle 
FA is greatest 
during 
menstruation and 
luteal phase 
 
FA is the smallest 
during the 
follicular phase 
and ovulatory 
phase 
Korninger et al. 
(1981) 
Turnover of 
Human tPA 
7 New Zealand 
white rabbits 
Injected tPA from 
purified cell culture 
fluids radiolabelled 
with 125I 
Half-life of 
injected tPA is ≈2-
3 min 
 
tPA is mainly 
cleared by the liver 
Nilsson et al. 
(1984) 
In vivo 
metabolism of 
human tPA 
2 healthy males Injected tPA from 
purified cell culture 
fluids radiolabelled 
with 125I  
Half-life of 
injected tPA is ≈3-
4 min 
 
tPA is mainly 
cleared by the liver 
Angleton et al. 
(1989) 
Diurnal variation 
on fibrinolytic 
potential 
I) 33 healthy men 
 
II) 15 patients with 
previous MI or 
unstable angina 
Resting blood 
samples were taken 
in the morning and 
evening in groups I 
and II. 
↓PAI-1 ACT 44% 
and 48% in groups 
I and II between 
morning and 
evening  
 
↑ tPA ACT 80% 
and 113% in 
groups I and II 
between morning 
and evening 
 
↓tPA AG 15% and 
23% in groups I 
and II between 
morning and 
evening 
FA= Fibrinolytic Activity, tPA ACT= Tissue Plasminogen Activator Activity, tPA AG= Tissue 
Plasminogen Activator Antigen, PAI-1 ACT= Plasminogen Activator Inhibitor 1 Activity, PAI-1 
AG= Plasminogen Activator Inhibitor Antigen, FA= Fibrinolytic Activity 
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Table 2.4. Methodological Considerations for Fibrinolytic Research (Continued). 
Study Problem Participants Design Finding(s) 
Winther et al. 
(1992) 
Effects of upright 
posture on 
fibrinolytic 
activity 
12 male volunteers Subjects assume 
the upright posture 
for 90 min, lay 
supine for 45 min, 
and then returned 
to upright posture 
for 90 min.  
↑tPA AG 64% by 
moving from a 
supine posture to 
an upright posture 
 
↓tPA AG 17% by 
moving from 
upright to supine 
posture 
 
 ↑FA 27% in 
upright posture 
versus supine 
posture 
Szymanski & Pate 
(1994) 
Fibrinolytic 
responses to 
moderate exercise 
in physically 
active and inactive 
men 
 
Fibrinolytic 
responses during 
morning and 
evening exercise 
I) 14 inactive men 
 
II) 12 active men 
Two 30 minute 
submaximal 
exercise sessions at 
50% of VO2max 
↑ tPA ACT ≈71% 
with evening 
exercise in active 
group 
 
↑tPA ACT ≈28% 
with morning 
exercise in active 
group 
 
↑ tPA ACT ≈25% 
with evening 
exercise in inactive 
group 
 
↑tPA ACT ≈8% 
with morning 
exercise in inactive 
group  
 
↔ in PAI-1 ACT 
with exercise in 
either group at 
either time point 
tPA ACT= Tissue Plasminogen Activator Activity, tPA AG= Tissue Plasminogen Activator Antigen, 
PAI-1 ACT= Plasminogen Activator Inhibitor 1 Activity, PAI-1 AG= Plasminogen Activator 
Inhibitor Antigen, FA= Fibrinolytic Activity 
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Table 2.4. Methodological Considerations for Fibrinolytic Research (Continued). 
Study Problem Participants Design Finding(s) 
Cooper et al. 
(2004) 
Temporal 
changers in tPA 
and PAI-1 after 
maximal exercise 
8 healthy males Subjects performed 
a graded exercise 
test using a 
treadmill ramped 
protocol until 
volitional 
exhaustion 
↑tPA ACT 19x 
from pre-exercise 
to 1 min post-
exercise period 
 
↔ tPA ACT from 
1 to 2 min post-
exercise 
 
tPA ACT↓ 
significantly by 4th 
min post-exercise 
as compared to 1st 
min post-exercise 
value 
 
↓PAI-1 ACT 56% 
from pre-exercise 
to 1 min post-
exercise. 
 
↔ changes 
observed in PAI-1 
ACT from 1 min 
post-exercise to 
any other post-
exercise time point  
Giardina et al. 
(2004) 
Variability of 
Hemostatic and 
Fibrinolytic 
Factors in Young 
Women 
20 pre-menopausal 
women 
Underwent blood 
testing across the 
menstrual cycle 
Difference in 
amount of 
estradiol between 
follicular and 
luteal phase mean 
∆= 30 pg/mL 
 
Change in 
estradiol 
associated with 
change in PAI-1, 
mean ∆= 14 
ng/mL 
 
Change in 
estradiol 
associated with 
change in D-
Dimer, mean ∆=57 
ng/mL 
tPA ACT= Tissue Plasminogen Activator Activity, tPA AG= Tissue Plasminogen Activator Antigen, PAI-1 
ACT= Plasminogen Activator Inhibitor 1 Activity, PAI-1 AG= Plasminogen Activator Inhibitor Antigen, FA= 
Fibrinolytic Activity 
  
Chapter Three 
Methods 
Participants 
 Twenty trained males, between the ages of 18-25, from the James Madison University 
community and the surrounding Harrisonburg area, agreed to take part in this study.  Two of 
these subjects dropped out of the study. The remaining 18 completed both treatment trials. 
Subject characteristics are summarized in table 3.1. Exclusion criteria included: any known 
cardiovascular, pulmonary, or metabolic disease; current tobacco use; current use of any 
medication known to influence fibrinolysis; infection; fever, or illness within 2 weeks prior to 
testing; garlic or flour allergy; and any other medical condition that could compromise safety.  
The questionnaire used to determine this information can be found in Appendix A.  Participants 
were provided with written and verbal information about the experimental procedures, including 
potential risks, prior to completing the informed consent form (Appendix B). All procedures were 
approved by the James Madison University Committee on Research Involving Human Subjects 
prior to testing.  
Table 3.1: Subject Characteristics 
 Age (yrs) Height (cm) Weight (kg) BMI 
Mean ± SD 20.9 ± 2.2 178 ± 7.7 75.5 ± 9.6 23.8 ± 2.3 
 
 Determination of Training Status 
 The short-form International Physical Activity Questionnaire (IPAC) was administered 
prior to testing (Appendix C). The IPAQ short form has acceptable reliability and criterion 
validity in men (Kurtze et al., 2008). The criterion for being considered trained in the current 
study was: A) 3 or more days of vigorous-intensity activity of at least 20 min per day or B) 7 or 
more days of any combination of walking, moderate-intensity or vigorous-intensity activities 
achieving a minimum total physical activity of at least 3000 MET-min*wk-1. 
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Supplementation 
Participants were given a packet containing either the placebo treatment (PT), which 
consisted of three gel capsules containing flour, or the garlic treatment (GT), which consisted of 
three 300 mg capsules of Kyolic Brand powdered aged garlic extract (Mission Viejo, CA). These 
treatment packets were administered in a randomized, double-blind, cross-over fashion to ensure 
that an equal number of participants performed the placebo treatment and the garlic treatment 
first.  Participants were instructed to ingest all of the tablets with a glass of water three hours prior 
to testing. Participants were also required to fast for 12 hours and abstain from alcohol 
consumption for 24 hours prior to testing. Adherence to the dietary restrictions was confirmed by 
a 24 hour food recall questionnaire administered prior to testing. All tests were performed before 
10AM to minimize the effect of diurnal variations (Angleton et al., 1989) and each participant 
was tested at the same time of day for both trials. 
Exercise Tests 
Treatment Trials 
 Participants reported to the Human Performance Laboratory on the campus of James 
Madison University’s in the morning after having supplemented with 900 mg of powdered garlic 
or a placebo. To control for any postural effects on fibrinolysis, participants assumed a semi-
recumbent position for 20 min prior to obtaining the baseline blood sample (Winther et al., 1992). 
Participants then completed a treadmill graded exercise test to volitional fatigue. Post-exercise 
blood samples were taken within two minutes of the cessation of exercise to avoid an immediate 
decline in tPA (Cooper et al, 2004). The final blood samples were taken one hour after exercise.  
Participants repeated the protocol with the other treatment two weeks later. 
Maximal Exercise Test 
Each participant performed a graded treadmill test on a Stairmaster Clubtrack 612 
treadmill (Kirkland, WA). The test began at an initial speed of 2.5 mph. Speed was then increased 
at a rate of 0.5 mph min-1 until 6.0 mph was reached. At this point, the treadmill speed remained 
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constant while the elevation increased at a rate of 3.0% * min-1 until 15.0% grade was reach. 
Speed was then increased once again at a rate of 0.5 mph min-1 until volitional exhaustion. VO2 
was continuously monitored with a Sensormedics Spectra metabolic cart (Yorba Linda, CA). This 
protocol has been previously shown to elicit a large fibrinolytic response (Paton et al., 2004; 
Cooper et al., 2004). 
Blood Sampling 
For each blood sample 5 ml of venous blood was collected in a tube treated with acidified 
citrate (Biopool International; Ventura, Calif) and an additional 5 ml of blood was collected in an 
EDTA tube. Whole blood collected in EDTA was analyzed for hematocrit using the 
microhematocrit method. The remainder of the EDTA sample and the blood collected in an 
acidified citrate tube were spun in a refrigerated centrifuge (4°C) at 10,000 rpm for 20 min to 
obtain platelet-poor plasma. Plasma was alliquoted and stored at -80°C until assayed. Fibrinolytic 
potential was determined by assaying for tPA activity, tPA antigen, and PAI-1 activity. tPA 
activity was determined by using an amidolytic activity assay (Biopool International; Ventura, 
Calif). tPA antigen and PAI-1 activity were determined using an enzyme linked immunosorbancy 
assay (ELISA) (American Diagnostica, Greenwich, Conn and Diapharma respectively). All 
values for tPA and PAI-1 were corrected for plasma volume changes (Van Beaumont et al., 
1972). 
Dietary and Exercise Controls 
Throughout the duration of the study participants were instructed to: 1) choose a standard 
“self-selected” meal plan for the 24 hours preceding the two treatment trials, 2) consume the last 
meal of the day no later than 12-hours prior to the treatment trials, 3) avoid consumption of 
alcohol 24-hours prior to each treatment trial, and 4) avoid exercise immediately prior to each 
treatment trial. Compliance with the dietary restrictions was confirmed via the administration of a 
24 hour food re-call questionnaire prior to teach treatment trial. Compliance was defined as a 
75% match between the garlic and the placebo trials’ food logs. Twelve of the 18 participants met 
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this criterion. However, the participants who did not meet this criterion did not report eating 
garlic the day prior to testing. Compliance to the exercise restrictions was confirmed verbally 
before each treatment trial. Participants were allowed to drink water ad libitum throughout the 
duration of the study. 
Statistical Analysis 
A two-factor (treatment and time) repeated measures analysis of variance (ANOVA) was 
used to assess changes in tPA activity, tPA antigen, and PAI-1 activity. The two within-subject 
factors were treatment condition (placebo trial (PT) and garlic trial (GT)) and time (pre-exercise, 
post-exercise, and 1 hour post-exercise). Post hoc tests were performed using two-tailed t-tests 
with a bonferroni correction factor. Differences in participant weight, resting hematocrit, 
VO2max, respiratory exchange ratio (RER), and treadmill time between the two treatment 
conditions were assessed via two-tailed paired t-tests. An alpha level of P<0.05 was set as the a 
priori level of statistical significance. 
  
Chapter Four 
Results 
Exercise Performance 
No significant difference (P > 0.05) was found between the two treatment conditions for 
weight [PT = 75.5 ± 9.6 kg, GT = 75.4 ± 9.8 kg], resting hematocrit [PT = 42.4 ± 10.9%, GT = 
44.9 ± 2.6%] or treadmill time [PT = 14.23 ± 1.3 min, GT = 14.15 ± 1.4 min]. One participant’s 
nose clip fell off during a trial and was therefore excluded from the VO2max analysis. A 
significant difference (P < 0.05) was found between the two treatment conditions for absolute 
VO2max [PT = 4.48 ± 0.47 L min
-1, GT = 4.61 ± 0.59 L min-1] and relative VO2max [PT = 59.8 ± 
6.7 ml kg-1 min-1, GT = 61.4 ± 6.6 ml kg-1 min-1]. No significant difference (P > 0.05) was found 
between the two treatment conditions for respiratory exchange ratio (RER) at VO2max [PT = 1.13 
± 0.05, GT = 1.13 ± 0.05]. 
Fibrinolytic Potential 
Two participants’ post-exercise blood samples were not obtained during the 2-min post-
exercise timeframe. These participants were excluded from the analysis of fibrinolytic variables. 
One participant was a consistent outlier (greater than two standard deviations above the mean) for 
tPA antigen and PAI-1 activity and was excluded from the analysis of fibrinolytic variables.  A 
Shapiro-Wilk test demonstrated that the data was not normally distributed for tPA antigen or PAI-
1 activity for at least one time point. These data were log-transformed prior to ANOVA.  Further 
analysis revealed that PAI-1 activity was still abnormally distributed after the log-transformation.  
The next highest outlier was removed from the analysis of fibrinolytic variables and normalcy 
was then achieved for PAI-1. The final sample size was 14 participants.  
 Figure 1 and 2 displays the mean tPA activity and tPA antigen response for the PT and 
GT. A significant (P < 0.000) main effect was observed for time for tPA activity. tPA activity 
significantly increased from pre-exercise [PT = 0.74 ± 0.08 IU ml-1, GT = 0.76 ± 0.07 IU ml-1] to
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post-exercise [PT = 19.5 ± 2.8 IU ml-1, GT = 19.8 ± 3.3 IU ml-1]. Compared to pre-exercise 
values, there was no elevation in tPA activity 1-h post-exercise [PT = 0.69 ± 0.10 IU ml-1, GT = 
0.69±0.06 IU ml-1]. There was no main effect for treatment (P = 0.91) and no treatment x time 
interaction (P = 0.99) for tPA activity. A significant (P < 0.000) main effect for time was 
observed for tPA antigen. tPA antigen significantly increased from pre-exercise [PT = 3.6 ± 0.46 
ng ml-1, GT = 4.8 ± 1.0 ng ml-1] to post-exercise [PT = 15.4 ± 1.8 ng ml-1, GT = 20.0 ± 3.1 ng ml-
1]. One hour post-exercise tPA antigen was reduced to a level not significantly different than pre-
exercise values [PT = 4.0 ± 0.52 ng ml-1, GT = 4.8 ± 0.80 ng ml-1] There was no main effect for 
treatment (P = 0.16) and no treatment x time interaction (P = 0.89) for tPA antigen. 
Figure 3 displays the mean PAI-1 activity response for the PT and GT. A significant (P < 
0.000) main effect was observed for time. PAI-1 activity significantly decreased from pre-
exercise [PT = 0.63 ± 0.10 ng ml-1, GT = 0.92 ± 0.22 ng ml-1] to post-exercise [PT = 0.16 ± 0.05 
ng ml-1, GT = 0.32 ± 0.13 ng ml-1]. There was no difference in pre-exercise PAI-1 activity and 
PAI-1 activity 1-h post-exercise [PT = 0.88 ± 0.17 ng ml-1, GT = 0.97 ± 0.21 ng ml-1]. There was 
no significant main effect for treatment (P = 0.40) and no treatment x time interaction (P = 0.617) 
for PAI-1 activity. 
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Chapter Five 
Discussion 
The primary finding of this study is that acute garlic supplementation does not improve 
the fibrinolytic potential or the fibrinolytic response to exercise in young, healthy, endurance-
trained men. These results support the findings of another randomized, placebo controlled, double 
blind study by Legnani and co-workers (1993) where no improvements in tPA activity were 
observed with acute garlic supplementation. Both studies had a young, healthy, participant pool 
which supplemented with 900 mg of garlic and had their fibrinolytic profile examined after 
approximately 4 hours. 
In contrast, several studies have described enhancement of the fibrinolytic system within 
a few hours after the consumption of garlic. Bordia and colleagues (1975) measured global 
fibrinolytic activity, using the euglobulin clot lysis method, following the administration of either 
50 grams of garlic along with 100 grams of butter or only 100 g of butter.  After 3 hours there 
was an observed 15% increase in fibrinolytic activity in the garlic trial but an observed 49% 
decrease in fibrinolytic activity in the butter only trial.  Chutani & Bordia (1981) found that 
fibrinolytic activity, also measured via the euglobulin clot lysis method, increased 72% and 62% 
after the administration of raw and fried garlic, respectively. Moreover, they saw the 
enhancement maintained for up to 12 hours. Kiesewetter et al. (1990) measured fibrinolytic 
potential following acute garlic supplementation and observed significant increases in tPA 
activity five hours after the administration of 300 mg and 600 mg of garlic (56% and 51%, 
respectively). Kiesewetter et al. (1990) also observed 600 mg of garlic to produce significant 
elevations in tPA activity in all participants. Jung and coworkers (1991) measured fibrinolytic 
potential following acute garlic supplementation and observed about an 86% increase in tPA 
activity after five hours. 
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The current study did not confirm these findings, possibly due to differences in the form 
of garlic administered.  Bordia et al. (1975) and Chutani & Bordia (1981) administered raw 
garlic. The main sulfur compound in raw garlic is alliin (Amagase et al., 2001). When garlic is 
cut or crushed, the enzyme alliinase rapidly lyses aliin to another sulfur compound known as 
aliicin (Block, 1985). Alliicin is extremely unstable and cannot be detected in the blood or urine 
after the consumption of raw garlic (Lawson et al., 1992). Allicin, perfused into rat livers, shows 
a large first-pass effect whereby allicin is converted to the metabolite diallyl disfulfide (DADS) 
(Egen-Schwind et al., 1992). Similar metabolites of allicin include the sulfides diallyl sulfide 
(DAS) and diallyl trisulfide (DAT) (Amagase et al., 2001). Kiesewetter et al. (1990) and Jung et 
al. (1991) administered commercial preparations of powdered garlic that had a standard 1.3% 
alliin content. Garlic powder retains the same ingredients as raw garlic and, when exposed to 
water, allinase rapidly converts alliin to allicin and subsequently the metabolites DAS, DADS, 
and DAT (Amagase et al., 2001). Like allicin, these sulfur containing compounds are metabolized 
quickly (Lawson et al., 1992), and therefore, they seemed unlikely to be the active ingredient that 
enhanced the fibrinolytic system acutely.  The supplement used in the present study, is a form of 
aged garlic extract (AGE) that is standardized to s-allyl cysteine (SAC). SAC is formed from the 
catabolism of γ-glutamyl cysteine, a sulfur containing compound separate from alliin (Amagase 
et al., 2001). SAC is a stable, odorless, and water soluble compound garlic (Amagase et al., 
2001). Unlike DADS, SAC can be detected in the plasma, liver, and kidney after the oral 
ingestion (Nagae et al., 1994). Because it is detectable in the blood and increases quantitatively 
following the oral intake of garlic, it is used as a compliance marker in human studies (Steiner & 
Li, 2001). SAC is also found in small quantities in raw garlic and garlic powder (Amagase et al., 
2001).  Thus, it is possible that differences in the active ingredient alter the hemostatic changes 
that occur with this form of garlic supplementation. 
In addition to feeding 50 grams of garlic along with 100 grams of butter to 10 healthy 
men, Bordia and coworkers (1975) also extracted garlic’s essential oil from 50 g of garlic and 
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then administered the essential oil to the same participant population.  After 3 hours there was an 
observed 15% increase in fibrinolytic activity. The essential oil of garlic is commonly obtained 
by one of two methods.  The first method is steam distillation whereby whole garlic is put into 
boiling water and the rising steam from the vessel is captured (Block, 1985). The second method 
involves grinding whole garlic cloves, adding them to water, and then having the oil fraction 
extracted in an organic solvent (Block, 1985; Amagase et al., 2001). Both of these processes 
completely eliminate the water-soluble components of garlic, such as SAC, but yield DAS and 
DADS (Block, 1985; Amagase et al., 2001). This suggests the acute enhancement in fibrinolytic 
potential by garlic may be derived from DAS and DADS rather than SAC. Further research 
should be conducted to better understand the relationship between the sulfur metabolites of alliin 
and their effects on fibrinolytic potential. If the sulfur metabolites of alliin are the active 
compounds in garlic which enhance fibrinolytic potential acutely, then inconsistencies in the 
literature would be explained as these metabolites are difficult to standardize and metabolize 
quickly. For instance Legnani & co-workers (1993) administered a comparable dosage of the 
same commercial garlic preparation to a comparable young, healthy, participant sample across a 
similar time course as Kiesewetter et al. (1990) and Jung et al. (1991), yet, could not confirm 
their results. 
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It is unclear as to whether or not our selected participant population contributed to the 
lack of an observed effect. Bordia & colleagues (1975) used a population of ten healthy males 
between the ages of 30-50 years and observed a 15% increase in fibrinolytic activity three hours 
after the ingestion of garlic. Chutani & Bordia (1981) used an older population of males, mean 
age 47.9 years, with a history of coronary artery disease and observed a 72% increase in 
fibrinolytic activity 6 hours after the ingestion of garlic. These two studies suggest age may have 
precluded an observed enhancement in fibrinolysis in the present study. In addition, the findings 
of Chutani & Bordia (1981) suggest a difference in health status may also have contributed to our 
observed lack of an effect of garlic. However, the comparison of our study’s participants to the 
participants in these studies is problematic. The outcome measure employed by Bordia & 
colleagues (1975) and Chutani & Bordia (1981) was the euglobulin clot lysis time, which does 
not directly measure changes in fibrinolytic variables.  Two of the studies which measured tPA 
activity did observe an increase in plasma tPA activity in a participant population similar to ours. 
Kiesewettier & co-workers (1990) examined ten apparently healthy participants, three women 
and seven men, with a mean age of 26.9 years and observed about a 50% increase in tPA activity 
after 5 hours. Jung & co-workers (1991) also examined ten apparently healthy participants, seven 
men and three women, with a mean age of 26.9 years and observed about an 86% increase in tPA 
activity after 5 hours. However, Legnani & coworkers (1993) also examined ten apparently health 
participants, three women and seven men, with a mean age of 25.5 years and did not observe an 
enhancement in tPA activity or tPA antigen or a decrease in PAI-1 activity after 2,4, or 6 hours. 
No details were given about the cardiorespiratory function of the participants in either the 
Kiesewettier & co-workers (1990) study the Jung & co-workers (1991), or the Legnani & 
coworkers (1993) study. Future research should be conducted to better evaluate the relationships 
between age, training status, and the effects of acute garlic supplementation on fibrinolytic 
potential. 
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An unexpected secondary finding of the present study is that acute garlic supplementation 
causes a slight but significant increase in VO2max in young, healthy, trained males without 
significantly increasing their treadmill time. Of the 17 participants whose gas exchange data was 
analyzed, 13 of them achieved a higher relative VO2max during the garlic trial than during the 
placebo trial. The average relative VO2max was 59.8 ml kg
-1 min-1 and 61.4 ml kg-1 min-1 for the 
placebo and garlic trials, respectively. Ince & colleagues (2000) administered a single dose of 
garlic to 10 college aged endurance athletes. Five hours after the ingestion of the garlic tablets, 
subjects underwent an incremental treadmill test according to the Bruce protocol. A significant 
difference was observed for VO2max, 57.3 ml kg
-1 min-1 for the garlic trial and 55.6 ml kg-1 min-1 
for the placebo trial, and treadmill time, 1033.6 s for the garlic trial and 990 s for the placebo 
trial. It was speculated that the observed differences between the garlic and placebo trials were 
due to improvements in the fluidity of the blood. They argue for a “rheological advantage” 
whereby whole-blood viscosity is decreased due to garlic-induced reductions in fibrinogen 
concentration. It was suggested that this reduction in fibrinogen concentration translates into 
better oxygen supply to the working musculature. Fibrinogen concentration was not measured by 
Ince & colleagues (2000) nor was it measured in the current study. But, Stuart & Kenny (1980) 
suggest hematocrit is the single most important determinant of whole-blood viscosity and in the 
present study there was no significant difference observed in hematocrit values at any of the time 
point across the two trials.  
Nitric oxide (NO) is an important cellular messenger involved in the functioning of the 
cardiovascular system which is synthesized from L- arginine by NO synthases (NOS) found in 
endothelial cells, smooth muscle cells, and platelets (Moncada et al., 1991). A special type of 
NOS, called endothelial constitutive (cNOS), is responsible for vasomotor tone (Moncada et al., 
1991). When cNOS is stimulated, NO is released from the endothelium (Kerwin et al., 1995). 
This causes a rapid and transient relaxation of arteries and veins to improve flow through vessels 
(Ignarro et al., 1991). Morihara & coworkers (2002) investigated the effect of AGE on NO 
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production via measurement of NO metabolites in the plasma of mice. An increase in NO 
production by 30-40% was observed from 15 to 60 minutes following the administration of AGE. 
It was also noted that a selective cNOS inhibitor, given to the mice prior to AGE, neutralized the 
enhanced NO production. This indicates that AGE increases NO production by activation of 
cNOS. In a subsequent study by Morihara & coworkers (2006), they examined the effects of 
AGE on NO production in rats engaging in repeated endurance exercise on a mechanical 
treadmill 5 times per week for 4 weeks. AGE significantly increase NO metabolites 2-fold as 
compared to the exercising control group which did not receive AGE. These studies suggest that 
AGE enhances NO production resulting in dilation of blood vessels. This may in turn enhance 
skeletal muscle perfusion and increase VO2max values. However, unpublished work from our lab 
did not find enhanced flow mediated dilation in the brachial artery following garlic 
supplementation, suggesting that it did not affect endothelium-derived NO. However, others have 
observed enhanced vasodilation with acute garlic supplementation. Jung et al. (1991) observed an 
increase in the diameter of erythrocyte column by 8.6% due to the vasodilation of pre-capillary 
arterioles. Similarly, Wolf et al. (1990) observed a slight dilation of conjunctival vessels due to 
garlic supplementation. Consequently AGE induced enhancement in vessel diameter may be 
limited to the microcirculation only. 
Interestingly, Morihara & coworkers (2006) also examined the impact of AGE on 
succinate dehydrogenase (SDH) activity. SDH is a key enzyme involved in aerobic metabolism as 
it plays a role in both the Kreb’s cycle and the electron transport chain (Oyedotun & Lemire, 
2004). AGE significantly increased SDH activity by 40% in the gastrocnemius muscle of the rats 
engaging in repeated endurance exercise on a mechanical treadmill 5 times per week for 4 weeks 
as compared to the control exercising rats which did not receive AGE. This elevation in SDH 
activity may indicate AGE enhances aerobic metabolism of skeletal muscle during exercise, 
which in turn may account for the increase in VO2max observed in the present study. 
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The functional importance of the observed improvements in VO2max is uncertain. The 
present study found a 1.6 ml kg-1 min-1 increase in VO2max without a corresponding 
improvement in treadmill time. Conversely, Ince & colleagues (2001) observed a 2 ml kg-1 min-1 
increase in VO2max as well as a 53.6 s increase in treadmill time. Both studies used groups of 
healthy trained college aged males. Future studies should seek to replicate the present findings to 
see if the lack of improved treadmill time persists.  
 Some limitations of the present study exist. The exact time course of garlic’s 
enhancement of the fibrinolytic system is not known. Baseline fibrinolytic measurements were 
taken approximately three and a half hour after the administration of garlic. This assumes there 
was not a transient rise and fall in fibrinolytic potential during this initial time period. This 
limitation is unlikely, however, as the present study’s time course was modeled on previous 
research which found no such transient rise and fall in fibrinolytic potential. The diet of the 
participants the day before each treatment trial was not stringently controlled in the present study. 
Dietary intake, particularly the intake of fat, can greatly influence fibrinolytic potential. Future 
research should control the dietary intake of participants by having them choose from a 
standardized meal plan option the day before each treatment trial. Participants in the present study 
were also young, healthy, trained males. Therefore, it is unknown if a similar result would be 
observed in untrained males, women, or clinical populations.  
 In summation, the present study does not support the hypothesis that acute 
supplementation with garlic enhances the fibrinolytic potential or fibrinolytic response to exercise 
in young, healthy, endurance trained males. Acute supplementation with garlic does result in a 
small but significant increase in VO2max. It remains unclear if these improvements in VO2max 
are of any functional importance.  
  
Chapter Six 
Summary 
 The primary aim of this study was to examine the potential effects of acute garlic 
supplementation on fibrinolytic potential and the fibrinolytic response to exercise in young, 
healthy, trained males with a randomized, double-blinded, crossover study design. We 
hypothesized that acute garlic supplementation would: 1) increase participants’ plasma levels of 
tPA activity and tPA antigen at rest, within 2-minutes post-exercise, and 1-hour post-exercise, 
and 2) decrease participants’ plasma levels of PAI-1 activity at rest, within 2-minutes post-
exercise, and 1-hour post-exercise.  
 In contrast to our hypotheses, acute garlic supplementation was found not to increase 
plasma levels of tPA activity or tPA antigen nor was acute garlic supplementation found to 
decrease plasma levels of PAI-1 activity. A possible explanation for the lack of an effect may be 
due to the form of garlic administered to participants. Notwithstanding, the results of this study 
suggest that acute garlic supplementation does not alter the fibrinolytic potential or the 
fibrinolytic response to exercise in young, healthy, trained males. Unexpectedly, acute garlic 
supplementation was found to cause a small but statistically significant rise in VO2max without a 
corresponding increase in treadmill time. This rise in VO2max may be due to increased nitric 
oxide production in the microcirculation as well increase activity of the aerobic enzyme of 
succinate dehydrogenase. It is not yet clear if this increase in VO2max is of any functional 
importance. 
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Appendix A 
James Madison University 
School of Kinesiology and Recreation Studies 
Health Status Questionnaire 
  
Instructions: Complete each question accurately. All information provided is confidential.  
Part I:  General Information  
  
1. Study: The effects of acute garlic supplementation on the markers of fibrinolytic potential following a 
bout of maximal aerobic exercise in young healthy untrained males 
 
2. Participant Number: 
  
3. Gender (circle one)  Male   Female  
  
4. Date of Birth  (Month/ Day/ Year) 
 
Part II: Medical History  
  
5. Circle any that died of heart attack before age 50:  Father  Mother  Brother  Sister  Grandparent  
   
  
6. Date of last medical exam: _____________ Last physical fitness test: _______________  
  
7. Circle operations you have had:  Back   Heart   Kidney   Eyes    Joint    Neck     Ears     Hernia     
                                        
        Lung     Other ________________  
  
8. Please circle any of the following for which you have been diagnosed or treated by a physician or health 
professional:  
  
Alcoholism     Diabetes       Kidney Problems  
Anemia (sickle cell)   Emphysema      Mental Illness  
Anemia (other)    Epilepsy       Muscular Injury  
Asthma      Eye Problems      Neck Strain  
Back Strain     Gout        Obesity  
Bleeding trait     Hearing Loss      Orthopedic Injuries  
Bronchitis, chronic    Heart Problem      Phlebitis  
Cancer       High Blood Pressure Rheumatoid arthritis  
Cirrhosis, liver     Hypoglycemia      Stroke  
Concussion     Hyperglycemia     Thyroid problem  
Congenital defect    Infectious Mononucleosis Ulcer  
Other _____________________  
  
9. Circle all medications taken in the last six months:  
 
Blood thinner    Epilepsy medication     Nitroglycerin  
Diabetic pill    Heart-rhythm medication   Weight Loss Medication 
Digitalis     High-blood pressure medication  Other __________________  
Diuretic     Insulin  
  
10.  Please list all vitamin, herbal, nutritional or other supplements that you are currently taking: 
 
 
11. Any of these health symptoms that occur frequently is the basis for medical attention. Circle the  
number indicating how often you have each of the following:  
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5 = Very often    4 = Fairly often   3 = Sometimes   2 = Infrequently   1= Practically never  
  
a. cough up blood     f. chest pain  
    1   2   3   4   5                   1   2   3   4   5  
  
b. abdominal pain     g. swollen joints  
    1   2   3   4   5                         1   2   3   4   5  
  
c. low back pain     h. feel faint  
    1   2   3   4   5                    1   2   3   4   5  
  
d. leg pain       i. dizziness  
    1   2   3   4   5                   1   2   3   4   5  
  
e. arm or shoulder pain   j. breathless on slight exertion  
    1   2   3   4   5                   1   2   3   4   5  
  
Part III: Health Related Behavior  
  
12. Do you smoke?  Yes No  
  
13. If you are a smoker, indicate the number of smoked per day:  
  
Cigarettes: 
 
 40 or more   20-39   10-19   1-9  
  
Cigars or pipes only:   
 
 5 or more or any inhaled  less than 5, none inhaled  
  
14. Do you exercise regularly? Yes No  
  
15. How many times in a week do you spend at least 30 minutes in moderate to strenuous/vigorous  
exercise?  
  
 1  2  3  4  5  6  7  days per week  
  
16. Can you walk 4 miles briskly without fatigue? Yes No  
  
17. Can you jog 3 miles continuously at a moderate pace without discomfort?  Yes      No  
  
18. Weight now: __________ lb.  One year ago: __________ lb   Age 21: __________ lb  
 
19. Height: __________  
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Appendix B 
Consent to Participate in Research 
Identification of Investigators & Purpose of Study   
You are being asked to participate in a research study conducted by Christopher J. Womack, Ph.D & David 
J. Lawton from James Madison University.  The purpose of this study is to determine the effects of acute 
garlic supplementation on markers of blood clotting following exercise.  
Potential Risks & Benefits 
If you choose to participate in this study, you will perform two separate treadmill exercise tests.  The 
investigator perceives the following are possible risks arising from your participation in the study: bad 
breath, belches with the taste of garlic, nausea, diarrhea, vomiting, discomfort, dizziness, and in rare 
occurrences, heart attack, stroke or death. The selection criteria used to obtain participants and the "Health 
Status Questionnaire" are intended to minimize these risks.  In healthy individuals, the risk of death during 
vigorous exercise has been estimated at 1 death per year for every 18,000 individuals.  Exercise testing will 
be performed by CPR-certified individuals with an automated defibrillator in the room.  Risks from blood 
drawing include infection, bruising and mild discomfort.   
 
Potential benefits from participation in this study include:  
 
1) Contributing to the body of knowledge regarding the health benefits of garlic 
2) Knowledge of your maximal aerobic capacity (VO2max) 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this consent form once all 
your questions have been answered to your satisfaction.  This study consists of two separate exercise tests 
performed on a treadmill.  All testing will occur in Godwin Hall, room 209, on the campus of James 
Madison University.  All tests will be performed on three separate occasions, separated by a 10-day 
washout period. You will also be breathing through a mouthpiece during all of the exercise tests so that we 
can analyze your expired air to determine how much oxygen you are using. Your heart rate will be 
monitored by a monitor that wraps around your chest.  
VO2max Test: During the VO2max test, you will begin walking at a low intensity (2.5 mph). We will then 
increase the speed of the treadmill by 0.5 mph each minute thereafter until 6.0 mph is reached. After this 
point the treadmill speed will remain constant while the elevation is increased at a rate of 3.0% for each 
minute until you indicate that you can no longer continue.  Between test preparation, completion of the 
exercise test, and the post-exercise period; this test should take approximately two hours. 
Supplementation: Ten days prior to each test, you will be asked to refrain from eating garlic or foods that 
contain the active ingredients of garlic. Immediately prior to each test, you will be asked to refrain from 
food and beverages (except water) for 12 hours. In addition you will be asked to abstain from alcohol 
consumption for 24 h prior to these tests The night before each test you will be given a packet containing 
either a placebo or 900 mg of powdered garlic in gel tablets. Neither the investigator nor you will know 
which treatment you received.  The investigator will obtain the pills from someone with the knowledge of 
whether you are receiving garlic or a placebo.  That person will not make this known to the investigator 
until after all testing is complete. You must ingest all of the tablets with a glass of water three hours prior to 
testing.  
60 
 
 
Blood Sampling: We will obtain about 10 ml of blood (about 2 tablespoons) prior to the treadmill test, 
immediately after the treadmill test, and 1 h following the treadmill test. These blood samples will be 
obtained from an arm vein.  
Confidentiality  
The results of this research will be presented at conferences and published in exercise science journals.  
The results of this project will be coded in such a way that your identity will not be attached to the final 
form of this study.  The researcher retains the right to use and publish non-identifiable data.  However, you 
can ask that your data be removed from the study at any point prior to presentation and publication.  While 
individual responses are confidential, aggregate data will be presented representing averages or 
generalizations about the responses as a whole.  All data will be stored in a secure location accessible only 
to the researcher.  Final aggregate results will be made available to you upon request. 
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you choose to 
participate, you can withdraw at any time without consequences of any kind. Your right to withdraw 
includes the right to request that your blood samples be discarded at any time. 
Questions 
You may have questions or concerns during the time of your participation in this study, or after its 
completion.  If you have any questions about the study, contact David J. Lawton at 
lawtondj@dukes.jmu.edu  
 
If you have questions or concerns during the time of your participation in this study, or after its completion 
or you would like to receive a copy of the final aggregate results of this study, please contact: 
 
David J. Lawton   Dr. Christopher Womack, Advisor 
Kinesiology    Kinesiology 
James Madison University  James Madison University 
lawtondj@dukes.jmu.edu  womackcx@jmu.edu 
     (540) 568-6145 
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Questions about Your Rights as a Research Subject 
Dr. David Cockley  
Chair, Institutional Review Board 
James Madison University 
(540) 568-2834 
cocklede@jmu.edu 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a participant in this study.  
I freely consent to participate.  I have been given satisfactory answers to my questions.  The investigator 
provided me with a copy of this form.  I certify that I am at least 18 years of age. 
 
 
  David J. Lawton 
Name of Participant  (Printed)  Name of Researcher(s)  (Printed) 
   
Name of Participant  (Signed)  Name of Researcher(s)  (Signed) 
   
  Date    Date 
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Appendix C 
 
International Physical Activity Questionnaire 
We are interested in finding out about the kinds of physical activities that people do as part of their 
everyday lives.  The questions will ask you about the time you spent being physically active in the last 7 
days.  Please answer each question even if you do not consider yourself to be an active person.  Please 
think about the activities you do at work, as part of your house and yard work, to get from place to place, 
and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical activities refer to 
activities that take hard physical effort and make you breathe much harder than normal.  Think only about 
those physical activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities like heavy 
lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
2. How much time did you usually spend doing vigorous physical activities on one of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities refer to 
activities that take moderate physical effort and make you breathe somewhat harder than normal.  Think 
only about those physical activities that you did for at least 10 minutes at a time. 
3. During the last 7 days, on how many days did you do moderate physical activities like carrying 
light loads, bicycling at a regular pace, or doubles tennis?  Do not include walking. 
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_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
4. How much time did you usually spend doing moderate physical activities on one of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at home, walking to 
travel from place to place, and any other walking that you might do solely for recreation, sport, exercise, or 
leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
The last question is about the time you spent sitting on weekdays during the last 7 days.  Include time 
spent at work, at home, while doing course work and during leisure time.  This may include time spent 
sitting at a desk, visiting friends, reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
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_____ hours per day  
_____ minutes per day  
Don’t know/Not sure  
   
This is the end of the questionnaire, thank you for participating 
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Appendix D 
 
24 Hour Food Log and Re-Call 
Daily Food Record 
Record all foods and liquids consumed in a single day.  Please be as specific as possible 
Date:  
Time Food/Drink Consumed and Method of Preparation Amount 
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